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ABSTRACf
An abstract of the dissertation of Kathleen Joan Oliver for the Doctor
of Philosophy in Urban Studies presented May 12, 1995.
Title: Behavioral and Community Impacts of the Portland ~eedle
Exchange Program.
Research questions were:
1: Will Drug Injectors Use An Exchange In A State
Where Syringes Are Legal?
2: Will Drug Injectors Using An Exchange Decrease
Risky Behavior?
3: Will Frequent Clients Change Risk Behaviors
More Than Infrequent Clients?
4: Will Drug Injectors Using An Exchange Change
Risk Behaviors More Than A Comparison Group Not
Using An Exchange?
5: Does An Exchange Have An Impact On The
Number Of Discarded Syringes On The Streets?
6: Is There A Differences In The Rate Of Spread Of
HIV Infection Among Users And Non-Users Of The
Exchange.
Drug injectors will use needle exchange programs, even in a
state where synnges are legal. During the first four years, nearly
2,O()() drug injectors made approximately 16,()()() visits to the
Exchange.
Clients of the Exchange reduced dsky behavior from intake to
six months. Change lasted over time: &t twelve months, change in
behaviors continued to be significant.
Frequent users of ~he Exchange were bettelr on two variables
than infrequent users: they borrowed syringes less, and were less
likely to use a syringe and throw it away.
Drug injectors using the Exchange were compared to those not
using the Exchange, but using a bleach/Qutreach project. Clients of
b~th projects reduced risky behaviors, with Exchange clients better
on two variables: re-using syringes without cleaning, and throwing
away used syringes. The two projects .attracted i different drug
injectors, and should be viewed as complementary rather than
competing AIDS prevention strategies.
The impact of the Exchange on the commu1nity was evaluated
by the change in the number of discardetd syringes found on the
streets. The number of syringes found per month decreased from
5.14 before the Exchange opened to 1.9 after it began -- a significant
side benefit.
The data presented here support tpe growing evidence that
needle exchange programs produce behavioral ri$k reductions, and
that the number of potentially infected syringes in public places can
be reduced.
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INTRODUCTION
The first needle exchange program in the world was
estalblished in Amsterdam in the Netherlands in 1984. It was
estalblished In response to concerns about transmission of Hepatitis B,
not HIV (Human Immunodefiency Virus). With the spread of HIV In
the 1980's, needle exchange programs were expanded in Amsterdam
and were begun in Great Britain, Sweden, and Australia.
Data from these countries were favorable concernIng use of the
programs by drug injectors, declines in risky needle use behaviors,
and lack of negative effects (Guydish, 1993). However, it has been
argued that the European experience may not be transferable to the
United States. (Guydish, 1993). There are cultural and ethnic
diffe~rences between drug injectors in America and those in Europe,
differences In legal access to drugs and injection equipment, as well
as differences in political climate.
The first needle exchange program In the United States was
started in 1988 in Tacoma, Washington. A small number of needle
exchange programs were soon established across the United States as
a rnteans of preventing HIV infection among drug injectors. The
needle exchange program begun in Portland, Oregon opened in 1989.
It was one of a handful of such programs nation-wide. Five years
later, there are still few programs in the United States -- only 37 by
July 1994.
2Fifteen years ago, HIV!' infection and AlDS (Acquired Immune
Deficiency SyndrOIpe) were virtually unheard of. : Today, over
250,000 cases of AIDS have I been reported to the I Centers for Disease
Control (CDC). Tbe first 100,000 cases occurred lover an eight-year
period. The second 150,000'. cases occurred over la three to four year
period (Lurie" 1994).
Risk factors associated with intravenous (IV) drug use are
found in one-third of people diagnosed with AIDS in the United
States (Lurie, 1994). Not OIilIy are growing numbers of drug injectors
becoming infected, but they I in turn infect their Icurrent partners,
their future partne~'s, and infants when they or their partners
become pregnant.
The response of the federal government to the presence of HIV
among drug injectors was first to ignore it and then to fund a small
number of outreacl'j/survey projects. AIDS was discovered in 1981,
and HIV was discovered two: years later in 1983. ' By 1984 it was
known that HIV was spread I by contaminated syringes. There were
no federally-fundeQ preventi~)ll programs for drug injectors until
1987. At that time: the National Institute for prug Abuse (NIDA)
funded National AlPS Demonstration Research (NADR) in 37 cities
across the United States. These projects adminis,tered surveys and
distributed bleach (Friedman, 1992).
The federal governmentl has placed five bans on use of federal
funds for needle qchange programs starting in 1988. The bans still
remain in effect d(~spite demonstrated effectiveness of such
programs, and despjte urgings to lift the ban from Centers for Disease
3Control and the National Research Council (organized by the National
Academy of Sciences).
The AIDS virus is most effectively transmitted through the
sharing of contaminated needles (i.e. direct blood-to-blood contact).
Prevention tactics directed towards drug injectors include outreach
and education, drug treatment, and use of bleach to disinfect
syringes before re-use. However, given that treatment is not an
option used or successfully used by all drug injectors, the most direct
intervention is furnishing drug injectors with access to sterile
needles so that sharing and re-use of equipment is not necessary.
Because of the controversial nature of needle exchange
programs, it is important to evaluate the benefits and liabilities of
such programs. This study is an evaluation of the Needle Exchange
Program in Portland, Oregon.
The Needle Exchange Program In Oregon was sited at Outside
In, a non-profit, social service agency in downtown Portland. The
agency has been providing services to low-income adults and
homeless youth since 1968. Current programs include primary care
and prenatal care clinics, and a homeless youth program which
provides a drop-in center, a 17-bed transitional housing program,
and support services.
Following is a brief discussion of the spread of HIV among drug
injectors both nationally and locally, and of how the disease is
transmitted among this group. The literature review presents four
models of behavior change theories that are applicable to change in
HIV risk behaviors, along with a discussion of the extent to which
4drug injectors might be expected to change risk behaviors In
response to the epidemic.
The response of communities and the federal government is
outlined. The benefits and limitations of methods other than syringe
exchange that have been implemented across the United States to
reduce sharing of syringes is presented. These include use of bleach
to clean syringes, enrollment in drug treatment programs with the
goal of future abstinence, outreach and HIV prevention education,
and legal sale of syringes. The response of the federal government
and its bans on use of federal funds for needle exchange programs is
also discussed. The literature review concludes with a rationale for
a harm reduction model in response to AIDS, and a rationale for
syringe exchange programs.
The methods section outlines how the Exchange worked,
including program protocols. It also describes the research
component, including recruitment of subjects, instruments and
interviews, the comparison group, blood tests, and methods of
tracking data.
The study asked the following questions:
Research Question 1: Will Drug Injectors Use A
Needle Exchange Program In A State Where
Syringes Are Legally Available Over-The-Counter?
Research Question 2: Will Drug Injectors Using A
Needle Exchange Program Decrease Risky Needle
Use Behavior Over Time?
Research Question 3: Will Frequent Users Of.A
Needle Exchange Program Chan~e Risk BfYhaviors
More Or Less Than Infrequent Users Of An
Exchange?
Research Question 4: Will Drug Injectors Using A
Needle Exchange Program Chan~e Risk Btrhaviors
More Or Less Than A Compariso~l Group Of Drug
Injectors Not Using A Needle E;l(change Pi'ogram?
Research Question 5: Does A N~edle Exchange
Program Have An Impact On TQe Community In
Terms Of A Change In The Number Of Discarded
Syringes On The Street?
Research Question 6: Will an Exchange result in
Differences In The Rate Of Spreqd Of HIV I Infection
Among Users And Non-Users Of The Needle
Exchange Program?
Results are presented for each of the ilbove questions. This
paper concludes with recommendations for improving exchange
programs and revising relevant laws, and recommend.ations for
further research.
Appendix A summarizes interviews of 18 clients of the
Portland Exchange who participated in the s~udy. Apl)endix B
provides a historical account of starting the program. Appendix C
presents updated research results from syringe exchange programs
5
in three other countries (The Netherlands, Australia, and Canada),
and Appendix D reviews results from four exchanges in this country
(New Haven, New York, San Francisco, and Tacoma).
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DESCRIPTION OF THE PROBLEM
SPREAD OF AIDS AMONG DRUG INJECTORS
Over 250,000 cases of AIDS had been reported to Centers for
Disease Control nationwide by 1993. Of these, one-third were linked
to IV drug use. Twenty-nine percent reported IV drug use, three
percent reported that their sexual partner (male or female) was a
drug injector, and one percent were infants born to drug injectors or
their sex partners. (Lurie, 1994).
In Oregon, HIV infections increased among drug injectors from
1.4% in 1989 to 2.3% in 1992 (Skeels, Oregon Health Division, 1993a),
and are now estimated to be about 4%. In Oregon, 2,261 cases of
AIDS were reported by September 1993. Of these, 7% were drug
injectors, and an additional 9% were both gay/bisexual and drug
injectors (Skeels, Oregon Health Division, 1993b).
Once established in a population, HIV can spread rapidly. In
New York the first three cases of AIDS in infants were
(retrospectively) diagnosed in 1977. The first case of AIDS In an
adult drug injector (who was also gay) was found in 1979. Five cases
of AIDS were found in adult heterosexual drug injectors III 1980
(along with three additional cases in gay drug injectors). In 1980
there were 8 cases of AIDS among drug injectors, in 1981 there were
31, in 1982 there were 160 and in 1983 there were 340. HIV testing
became available in the summer of 1984. Test results indicated that
8by then half of New York's IV drug users were testing HIV positive
(Des Jarlais, 1992a).
In Bangkok, Thailand the HIV infecltion' rate among drug
I
injectors also rose rapidly, from zero to 50% :in less than two years.
I
(Friedman, 1991a). However, it is not always the case that HIV
infection rates will increase rapidly once infetetion is established III a
population group. For example, in San Francisco the infection rates
have stayed between 10% and 20% for ~~e:ver:cll years. (Friedman,
1991a). Other cities around the world have ;also maintained a
I
seroprevelence rate of less than 15%, in~~luding Hamburg, Sardinia,
I
Vienna and Tours. (Friedman, 1993). Reason!:s for differences in the
I
spread of HIV between communities is not fully understood, and in
I
fact the World Health Organization is funding studies in Asia,
Australia, Europe, North America and South America specifically to
I
investigate these differences. (Friedman, 19913).
Transmission of HIV Among Drug Injech)rs
HIV is transmitted among drug inj~ctors through sharing of
injection equipment, sexual contact, and perinatally during
pregnancy. However, the most common il~ld /efficient mode of
transmission is through sharing of equipment" Shared equipment
I
refers primarily to syringes, but can also include cookers, cotton and
ri nse wa teT.
Syringes are contaminated when infected blood remains in the
,
,
syringe or on the needle. Cookers are e9uipment used to "cook" the
drug prior to injecting. They are often spoons or bottle caps (bottoms
9of aluminum beverage cans are common). Cookers become
contaminated when already-used syringes are used to draw up the
drug, and blood is injected into it. Cotton is used to strain the cooked
drug to remove residue as the drug is drawn into the syringe. It
may become contaminated if the cooker was contaminated, or if it is
used more than once and a syringe was infected. Rinse water is
utilized to rinse syringes between uses to clean away residue and
prevent equipment from clogging. It becomes contaminated if a
syringe is contaminated. Provision of sterile syringes and other
materials needed for safe, sterile injections eliminates most of these
opportunities for contamination and is the most effective barrier
against transmission of HIV among this population.
The primary reason for sharing of syringes is probably scarcity
of equipment, and fear of legal consequences if syringes are in one's
possession. Laws in most states prohibit or severely restrict sale of
syringes to drug injectors, making syringes a scarce commodity
among this group. Laws also make possession of syringes a crime,
and those found carrying them face legal consequences.
However, there are also reasons for sharing syringes that are
social, and involve issues of trust and group norms. Sharing,
particularly with a sex partner or "running" partner, can indicate
trust in the partner. Sharing can also indicate trust among friends, or
simply be an expectation or norm of the group. Effective
intervention programs will not only make syringes readily accessible,
but will attempt to change individual and group norms.
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The pnmary public poli~:y responses to drug use and drug
injectors in the United States have been treatment programs and
laws to prohibit drug use and punish drug injectors. Harm reduction
programs such as provision of bleach or needle exchange are viewed
as counter-productive to thesE', effiorts.
However, AIDS has changed lour world, and existing public
policies have been unable to take linto account the new epidemic.
Increasingly, old drug policies are viewed as ineffective and counter-
productive in stopping the spre~ld of HIV. Drug use and AIDS exist In
conjunction with one another, ilnd public policies can no longer
consider them in isolation frorn ea:ch other.
REVIEW OF THE LITERATURE
BEHAVIOR CHANGE THEORY
Behavior change theories provide frameworks for assessing which
techniques for altering behavior will likely be effective. Behavioral
theories which are relevant to changing HIV risk behaviors among
drug injectors include the Health Belief Model and the Theory of
Reasoned Action or Theory of Planned Action. In addition, the
Information-Motivation-Behavioral Skills Model and the AIDS Risk
Reduction Model are theories which have been developed directly in
response to AIDS, and focus solely on influencing HIV risk behaviors.
Health Belief Model
The Health Belief Model looks at behavior change in a
population that is susceptible to a health problem. This model grew
out of work by Irving Rosenstock and others at the United States
Public Health Service in the 1950's and 1960's. The focus of the
Public Health Service was on prevention rather than on treatment of
diseases. However, screening tests, annual physicals and other
simple preventative measures offered people often were simply not
used. People did not believe that they were susceptible to a
particular disease, that the effects of the disease would be severe, or
that they could take action to prevent the disease.
•12
The Health Belief Model, as reviewed by Rosenstock (1988),
hypothesizes that change occurs in health-related behaviors only
I
upon satisfaction of three conditions:
• Motivation to make a health issue relevant and of cqncern.
I
• "Perceived threat." That is, a belief that the person IS
I
vulnerable to a disease or health problem that has
significant negative consequences.
Belief that taking action will reduce Ilhe I perceived tbreat,
I
and that the benefits of doing so will outweigh the costs.
In other words, people must feel threate:nedl or susceptjble,
wish to attain or sustain health, and believe that (;hange will result in I
benefits for themselves at an acceptable cost. However, they must
also believe that change is possible.
This belief that change is possible was incOirporated intq the
I
Health Belief Model by Janz and Becker (1984)..They reviewed
forty-six Health Belief Mode! studies and founld tlhat "perceived
barriers" was the most significant factor in behavior change. Because
I
the model looks at the subjective world of the individual, an
important element is the individual's estimation! of the feasibility of
I
change.
The Health Belief Model appeared to havte potential to be a
I
particularly useful model in understanding and c1hanging HIV-related
risk behaviors. Rarely has there been a more sig,nificant heaUh
threat than AIDS -- especially to groups such as gay men. Seldom
I
has a group changed behavior to the extent that gay men hav~ in
I
response to this threat. However, an evaluation bo/ Kirscht and
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Joseph (1989) found that using this model to predict HIV-related
behaviQr change among gay men provided mixed results. They
concluQed that behavior change is a very dynamic and complex
process~ and perhaps one model alone is insufficient to fully
underst~nd this process.
Theory of Reasoned Action
The Theory of Reasoned Action was first introduced by Ajzen
all1d Fishbein in 1967. It was developed as a model which could
explain any behavior under consideration. It is based on the
assumption llhat people are rational beings, and behavior is not a
function of automatic or unconscious motivations. Thus the model IS
called the Theory of "Reasoned Action."
Ajzen and Fishbein (1980) based their theory on the
assumption that intentions determine behaviors, that is, people
generally do what they intend to do. Intentions are determined by a
person's attitude toward the behavior, subjective norms, and the
relative importance or weight of each. Attitudes towards the
behavior are the personal factor, and can be defined as the positive
or negative evaluation of the behavior. Subjective norms (or social
pressurt;.s) are the result of perceived favorable or unfavorable
attitude~; of others towards the behavior, and the person's motivation
to confprm. The relative importance of attitudes and subjective
norms ~nust also be considered.
Attitudles and subjective norms are determined by beliefs.
Attitudes are determined by a belief that the behavior in question
14
will have a desirable outcome, and an evaluation of that outcome.
Subjective norms are determined by beliefs regarding whether
others will approve or disapprove of the behavior, and the person's
motivation to comply with social pressure.
Laflin (1994) pointed out that it is important to note that, first,
behavioral intentions do not exactly correspond to resulting
behaviors. Second, a critical element is the extent to which one has
control over the behavior. This concept is called volitional control.
Volitional control can be actual control possessed by the
individual, or perceived control. This concept was judged to be of
such importance that Ajzen refined and renamed the theory (Ajzen,
1980). The new theory is the Theory of Planned Action. This new
theory posits "perceived behavioral control," which is control a
person perceives her/himself as possessing, as opposed to control
he/she may actually possess. Perceived behavioral control is added
to subjective norms and attitudes which then lead to behavioral
intentions which in turn lead to behaviors (Laflin, 1994).
Fishbein and Middlestadt (1989) advocate use of this theory
specifically to attempt to understand and change AIDS-related
behaviors. They stress the importance of selecting and specifying a
single behavior, and selecting one that IS under volitional control.
Then research should be done to identify beliefs held by the target
group. Only then should interventions be designed. Too often
interventions are developed which are based on untested intuition
rather than on theory.
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Information-Motivation-Behavioral Skills Model
Fisher and Fisher (1992) reviewed AIDS education programs,
and found that those that were most successful were based on a
formal theory, were group-specific, and performed "elicitation
research. II Elicitation research is an assessment before the
intervention is implemented of the target group's knowledge! factors I
that influence their motivations, and the extent or level of behavior
skills.
The Information-Motivation-Behavioral Skills (1MB) mc)del was
proposed by Fisher and Fisher (1992) as a formal theory specifically
to aid in designing education and intervention programs to reduce
HIV risk behaviors. The three components of the 1MB model are
information about AIDS, motivation to change and the behavioral
skills necessary to allow and facilitate change. Elicitation reS/earch
and evaluation are also important components of the model.
The first component of the model, AIDS information, is seldom
sufficient by itself in eliciting and sustaining change. It is ab~e to
produce change only when the behavior in question IS fairly
uncomplicated. It is, however, a necessary element of the m9del.
Elicitation research must be done to determine AIDS prevent jon
knowledge, and it must be population-specific. Results are tben used
to determine which type of AIDS information will be most useful.
Motivation, the second component of the model, is necftssary
because full, accurate information and high levels of behavior skills
are insufficient in producing change if the person is not motivated to
16
change. Factors affecting motivation are sodal norms and the
individual's attitude towards HIV prevention.
The 1MB model draws from the Healtb Belief Model and
Fishbein and Ajzen's Theory of Reason~d Action to help identify
factors that may determine motivation. Factors from the Health
Belief Model include perceived risk to HI V, i and perceived costs and
benefits of changing behavior. Concepts taklen from the Theory of
Reasoned Action are that actions resuH from behavioral intentions
which in turn result from social norms and the individual's attitudes.
To influence motivations, work must b~ done on both attitudes and
perceptions of norms.
Both information and motivation work through behavioral
skills to influence HIV risk behaviors. There are both universal
behavioral skills (publicly buying condoms, obtaining an HIV test or
not engaging in sex if negotiations for safer isex practices with a
partner fail), and population-specific b~havi()ral skills relevant, for
example, to African-American women, minors who are drug
injectors, etc. The 1MB model also states th;at one must not only have
behavioral skills, but must believe one is personally able to use
them.
Once information has been given, moqvations for change
strengthened, and behavioral skills tau~~ht, evaluation should test
whether change occurred. The evaluatipn should assess change in
attitudes, motivations, behavioral skills, and ithe extent to which
change is maintained over time.
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AIDS Risk Reduction Model
Catania, Kegeles and Coates (1990) developed a behavior
change theory also specifically focused on HIV risk bebaviors, tbe
AIDS Risk Reduction Model (ARRM). This model recognizes that I
behavior change is a process, and separates out components of the
process. The three stages of ARRM are (1) recognition and labeling
one's behavior as problematic, (2) making a committed decision :to
change the behavior, and (3) seeking and carrying out solutions Ito
achieve the desired change.
The first step is to recognize that one's behavior is placing one
at risk for AIDS. Variables that influence this stage inqlude HIV I
transmission knowledge, believing one is personally v4lnerable to
the disease, and believing that contracting AIDS would be an
undesirable outcome. Social factors (networks, norms, friends,
partners) can also be influential at this stage.
The second stage is the decision-making stage, and comes I
between labeling one's behavior as problematic and carrying outl
change. Variables that influence this stage include per~eived costs
and benefits of changing the behavior, self-efficacy (pe;.rceived ability
to make the change), and social factors (i.e. observing that others
have successfully changed behavior).
The third stage is to take action. This stage in turn has thnte
steps: (1) obtaining information, (2) finding solutions, qnd (3)
making changes that result in the solutions. Information may be:
obtained passively through the media, or through activ~ly seeking
help. It could be influenced by past experiences with ~eeking
18
information, self-esteem, lmd how important the problem is
perceived in relation to other probllems. Finding solutions can range
from seeking professional help to personal decisions to change.
Enacting the solution is influenced by emotional state (degree of
distress or anxiety about pne's riskt), social factors and other external
factors (such as alcohol/drug use).1
By emphasizing ch'mge as Cl. process and breaking down the
process into stages, the ARRM model hopes to identify where people
are in the process. AIDS educatorls can then accurately target
appropriate interventions.
Behavior Change Among prug Injectors
There has been som~ questiom as to the extent to which drug
injectors would be able to change their behavior in order to protect
themselves from AIDS. Most are addicted, and drug use is a primary
motivation and focus of their lives. I This, and the fact that they are
often high, can interfere with other motivations such as protecting
their health and safety and protecting themselves from AIDS.
However, to depict drug injectors as unconcerned with their health
and safety is to do them ~ disservice.
There have now been many Istudies showing that drug injectors
place a high value on avoiding AIDS and have made at least some
changes in their behavior~o avoid :the disease. Studies include those
by Friedman (1991b), Des Jarlais (:1991), Saxon (1994), Anderson
(1993), Stephens (1991), McCusker (1992), and Des Jarlais (1987).
Surveys of drug injectors in New York as early as 1983-1985 showed
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an increased demand for new syringes (Des Jarlais, 1985). However,
sharing syringes can be a complex social event, with motivations that
have little to do with simple scarcity of injection equipment.
A study was conducted by Howard and Borges (1970) in San
Francisco well before the onset of the AIDS epidemic. Reasons for
sharing syringes were (1) scarcity of equipment, (2) sharing as a sign
of friendship and trust, (3) sharing as a norm of the subculture, (4)
sharing as a means of socialization to the subculture, (5) sharing as
protection against a "bad trip" or overdosing when alone, (6) sharing
as a means of achieving social status, (7) sharing as a substitute for
means of achieving social status, (8) sharing as a substitute for sex,
and (9) sharing as a conscious or unconscious attempt at self-
des tru cti on.
In comparison, a study was done by Magura (1987) well after
AIDS had become a visible disease. Contrary to what might be
expected, neither knowledge of AIDS nor knowing someone with
AIDS was associated with reduced sharing of needles. Also not
associated were sex, age, ethnic background or marital status.
Factors which did influence needle sharing were (1) "attitudes
conducive to sharing," either a fear that friends would be "insulted,"
or an unwillingness to go through withdrawal rather than not share
equipment, (2) lack of equipment and perceived economic barriers to
obtaining equipment, (3) IV drug use by peers (sexual partners and
friends), and (4) "perceived utility of risk avoidance," (i.e. to stop
sharing is likely useless as they have probably already contracted
the disease).
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Different studies using different instruments and methods and
conducted with different populations have yielded somewhat
different results. Recent studies also now show that drug injectors
have reduced sharing of syringes and other risky needle use
behaviors in response to the dangers of contracting HIV: Friedman
(1987), Des Jarlais (1985), Friedman (1991b), Watters (1990),
Stephens (1991), Calsyn (1992), Booth & Watters (1994), and Saxon
(1994). It does appear, then, that reasons for sharing or not sharing
syringes have changed over the course of the AIDS epidemic.
What has not changed is that sharing of syringes is not simply
the result of scarcity of injection equipment, but that it continues to
be a complex social behavior. However, AIDS has changed risks
associated with sharing of syringes, and consequently can be
expected to have an effect on attitudes and behaviors. Behavior
change theories which are oriented to disease prevention are likely
to be applicable.
TECHNIQUES FOR CONTROLLING THE EPIDEMIC
Use of Bleach
Transmission of HIV among drug injectors is primarily through
sharing of contaminated drug injection equipment, and secondarily
through sexual contact. Use of bleach to disinfect contaminated
injection equipment has been a primary approach to HIV prevention,
particularly in states where over-the-counter sales of syringes are
prohibited by law.
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As described by Friedman (1993), San Francisco developed the
first program to distribute bleach packaged in small, convenient
bottles. Distribution of bleach was considered because sale of
syringes to drug injectors is illegal in California. Giving out bleach
also helped outreach workers gain the trust of drug injectors, and
was a means of entry into the subculture. Bleach outreach programs
quickly spread to other cities across the United States.
However, use of bleach to prevent AIDS is now called a
"second-rank intervention" There has been insufficient research to
be able to say definitively how bleach should be used to adequately
disinfect syringes; syringes were not designed to be cleaned and
reused; and drug injectors do not always follow all the procedures
recommended to adequately disinfect injection equipment.
For bleach to be effective in eliminating risk of transmission of
HIV, it must fulfill two conditions. First, it must be able to sterilize
contaminated syringes, and second, it must always be used properly.
A study conducted by Martin (1994) for the Centers for Disease
Control and Prevention (CDC) called into question the absolute
scientific validity of saying that use of bleach to clean syringes
always kills HIV. Using bleach to kill HIV in a laboratory is likely
different than using bleach on HIV that is mixed with blood and
other materials in a syringe.
Chlorine's disinfection ability is determined by the
concentration of free and available chlorine in the
solution. This is affected by the temperature, the
presence of organic material, the pH, and the hardness of
the water. Chlorine compounds usability may be limited
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by the corrosiveness and instability. Serum proteins or
other organic material in blood will react when mixed
with chlorine compounds and reduce the chlorine
available for microbial inactivation.
The report further stated that:
It is not surprising that the use of bleach for disinfection
for syringes and needles contaminated with blood may
not result in complete inactivation of cell-free HIV. The
presence of organic material such as blood, liquid or
dried, the absence of precleaning or rinsing with water,
and the difficulty of cleaning a device not designed for
reuse are all complicating factors.
A recent study by McCoy (1994), tested blood from known HIV
positive drug users. Blood was placed in syringes and left for
varying times up to 24 hours (to simulate needles found in shooting
galleries). Techniques for cleaning with bleach taught to drug
injectors by outreach workers were used in the laboratory.
The study found that syringes cleaned for 30 seconds had no
evidence of HIV, that those cleaned for 15 seconds may or may not
retain HIV, and those left uncleaned retained HIV for 24 hours.
Drug injectors were then taught bleach-cleaning techniques.
Drug injectors were followed up six months later to demonstrate
cleaning methods they had been taught. They recalled basic
techniques well, but had less recall of more detailed techniques.
A study by Titus (1994) of drug injectors in New York called
into question the extent to which bleach actually protected against
HIV infection. Drug injectors who bad sero-converted were
compared to a control group who remained sero-negative. All
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subjects were asked about sharing of syringes and use of bleach
every three to six months. Risk factors associated with sero-
conversion were sexual contact with a HIV-infected person, and
frequency of use of speedballs (cocaine mixed with heroin). Use of
bleach did not protect subjects from HIV.
Finally, a study by Gleghorn (1994) in Baltimore, Maryland
videotaped drug injectors cleaning syringes. Drug injectors were
taught cleaning techniques using the recent guidelines issued for use
of bleach that recommended thirty seconds of contact time with the
bleach. Of 85 drug injectors videotaped, 68 (80%) had a contact time
of less than thirty seconds. There is some question, therefore
whether drug injectors use practices that adequately disinfect
injection equipment.
What we now know about cleaning syringes with bleach is that:
• Multiple cleanings with bleach are likely better than a single
cleaning.
• The less amount of blood and other material in the syringe
the easier it will be to disinfect it.
• Agitating the syringes is preferable.
• The longer bleach is left in the syringe the better.
• The more steps a drug injector has to go through, and the
longer it takes to clean a syringe, the less likely they are to
clean syringes thoroughly and consistently.
For all the reasons stated above, bleach is now considered a
"second-rank intervention." Using a new, sterile syringe for every
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injection is the ideal intervention, and bleach is recommended for
use only when sterile syringes are not available.
The above accounts of possible problems and ineffectiveness of
bleach does not mean that advocating among drug injectors for use of
bleach to clean syringes should be abandoned. There are times when
new, sterile syringes are not available, and there is some indication
that some groups of drug injectors find bleach an acceptable
prevention strategy, even when syringes are legally available. Saxon
(1994) studied drug injectors in Seattle who were provided with HIV
prevention education. A survey administered at intake and 18
months later showed that use of bleach increased from 10% to 25%
in a state where syringes could be legally purchased in pharmacies.
Use of bleach to clean syringes is clearly viewed by some drug
injectors as a risk reduction technique that is appropriate for them.
Multiple intervention strategies are preferable. Different
prevention tactics are appropriate with different groups of drug
injectors. From a harm reduction perspective, people ought to be
instructed in the most up-to-date methods of cleaning with bleach,
told that using a sterile syringe for every injection is likely safer, and
have both bleach and sterile syringes available to them.
Drug Treatment Programs
A second tactic to control the spread of the AIDS epidemic
among drug injectors (other than use of bleach) is drug treatment
programs. The ultimate answer is for drug injectors to stop injecting
drugs. This would eliminate all risk of transmitting the AIDS virus
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through transmission of contaminated blood. This is the abstin{/,ncf~
approach. Drug injectors must stop injecting, and if theyl don't,
resulting health problems are their own fault. Until they enter
treatment, they are not worth the expense of time a~ld elffort.
Treatment and abstinence are long-term solutions for control of
the spread of HIV among drug injectors, but do not addr,ess the
immediate problem of IV drug use. Realistically, the majority of
drug injectors are unlikely to enter treatment immediately,
successfully complete it, and remain clean thereafter. Many drl\g I
injectors are uninterested in treatment programs, and malny who go
through treatment programs relapse.
Residential or hospital-based treatment progra~ns \Ire generalily
successful in ensuring clients are drug free. However, wlhen clie;ntsl
are released, it is difficult for them to maintain behavior I change!
particularly if they return to the environment where they used to
use drugs. Only 15% to 25% of people receiving dru~ treatment one
time only are able to maintain abstinence permanently (IDes Jarlilis,1
1991) .
Further, on both a national and local level, only a simall
proportion of drug injectors are able to be in treatm~nt !programs.
The National Institute on Drug Abuse (NIDA) estimate;s 1.11 to 13
million drug injectors in the United States. At any given time, npt
more than 15% are in drug treatment programs (Lurie, 11994).
Locally, there are an estimated 7,000 drug injectors jn Multnomllh
County, Oregon, the county which includes the City of Por:t1and. At I
any given time, not more than 19% are in treatment (pertsonal
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communication, Jeanne Gould, Director of HIV and STD Programs,
Multnomah County Health Division, 1990).
It is ironic that although everyone, including both supporters
and opponents of needle exchange programs, agree that increased
treatment capacity is a necessary step in fighting AIDS among drug
injectors, and ultimately the most effective prevention measure, little
has been done to expand treatment program capacity in the United
States. The AIDS epidemic started in 1981. Over the next five years,
from 1982 to 1987, treatment program capacity increased by 30,000
slots in methadone, residential and hospital-based treatment
programs (from 89,000 slots to 119,000 slots. National Institute on
Drug Abuse (NIDA) estimates that there are approximately 1,000,000
drug injectors in the United States. The increase of 30,000 treatment
slots provides for only 3% of drug injectors. (Friedman, 1992).
For this method to be effective, treatment should be available
for anyone who wishes it. There are currently waiting lists for drug
injectors who wish to enter treatment programs. If treatment
programs were more available, there is evidence that many drug
injectors would avail themselves of these programs (Friedman,
1992) .
As reported by Jackson (1990), New Jersey began one of the
earliest, largest and most organized efforts to get drug injectors into
treatment. New Jersey was hard-hit by the AIDS epidemic, and
transmission of the virus in that state was primarily among drug
injectors, either by sharing of contaminated injection equipment or
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through unprotected sex. By 1990, it was estimated that
approxiimately 50% of drug injectors in this state were HIV positive
As the AIDS epidemic was beginn;ng in thie early 1980's, the
federal government cut funds for drug treatment programs. As a
result, New Jersey cut treatment programs and required drug
injectors to pay for treatment services. Between 1980 and 1985
there was a 79% decrease in the number of heroin users entering
detoxifiication programs.
In 1985, New Jersey began to use outreacb workers (funded by
the Centers for Disease Control and Prevention) to educate drug
injectors. These outreach workers repor(ed that ITIOre than half of
these drug injectors would enter treatment if they could afford it.
New Jersey health officials decided that treatment: must be free, and
waiting lists must be eliminated.
A coupon system for treatment was implemented in 1986.
That year, 1,000 coupons for free, imm~diate drt.:lg treatment were
made available to heroin users. Of these, 970 were actually
distribut,ed, and 86% were redeemed for treatmentl. The following
year, about 2,000 heroin addicts redeem(~d coupo!ns for treatment.
The New Jersey experience demonstrated tbat many drug
injectors wish to enter treatment programs, and dol not do so only
because of barriers that prevent them fro~TI using the programs. If
treatmenll programs are free and availabl~ on demand, a significant
number of drug injectors will use them.
There is now evidence that treatme.nt prote<.tts against
transmission of HIV, and that methadone maintenance is more
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effective than residential care or outpatient treatment. One of the
primary methods of treatment for long-term heroin users is
methadone maintenance. Methadone maintenance was developed by
Drs. Vincent Dole and Marie Nyswander in the early 1960's. They
found that addicts given methadone were able to improve their
ability to function. Further evaluations of methadone maintenance
substantiated their findings. Clients of methadone programs tend to
remain in treatment longer, and length of time in treatment is a
strong predictor of success in remaining drug-free. Cooper (1989)
found that within the first few months of treatment 15% of
methadone clients leave the program compared to 40-50% of clients
of residential and outpatient programs. Addicts maintained on high
doses (120 mg per day) of methadone are twice as likely to remain
in treatment and three times less likely to die (Caplehorn, 1994).
Recent evaluations have made a connection between treatment
and reduced risk for HIV. A study by Saxon (1994) showed that the
amount of time spent in treatment during an eighteen-month period
was inversely correlated with sharing of syringes. Liebman (1993)
also found that the longer drug injectors remained in treatment
programs, the greater was their reduction of risky needle use
behaviors.
Ball (1988) conducted a three-year study of six methadone
programs in New York, Baltimore and Philadelphia. This study found
that 71 % of 388 program clients had stopped IV drug use, and most
had done so for over a year. A major finding of this study was that
differences among the programs accounted for significant differences
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In effectiveness in reducing IV drug use among clients. IV drug use
varied among program clients from 10% to 57%.
A study by Barthwell (1989) conducted blinded HIV tests on
clients of methadone programs in Illinois. Only 12% of clients were
HIV positive, compared with approximately 20% of street
populations of drug injectors. This provides strong indication of the
protective effects of methadone treatment programs.
The evidence suggests that methadone treatment programs
ought to be expanded. Those who advocate for a drug-free outcome
as the result of treatment have difficulty with methadone programs.
Nonetheless, methadone treatment is a harm-reduction tactic that
reduces the incidence of injection of illegal drugs and transmission of
HIV. It may be the best option for some drug injectors who are
moving along the continuum between heavy involvement in illegal
drug use (and risky behaviors) and abstinence.
Because drug injectors are vulnerable not only to drug
addiction, but now also to AIDS, it is critical to have a fluid, less rigid
model that does not insist on treatment and abstinence before
working with clients. Rather, a harm reduction model works with
people as they are and helps them reduce their drug use and
exposure to HIV to the extent they are able to do so. This model
recognizes that behavior change is gradual, and that while
elimination of risky behaviors is the goal, incremental reduction of
risky behaviors over time is more realistic.
Treatment programs are a critical component III fighting HIV,
but cannot be relied on as the answer to the epidemic. As stated
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earlier, not all drug injectors are interested in treatment, and only
15-25% of those using treatment programs one-time-only remain
free from relapse. For drug injectors who are not yet ready for
treatment programs and for those who relapse, HIV education and
availability of bleach and sterile syringes are important AIDS
prevention measures.
Outreach and Education
Educating drug injectors about the AIDS virus and how they
can protect themselves from it is the necessary first step in AIDS
prevention. They must have sufficient information about how the
virus is transmitted, and commonly-held myths must be dispelled
(i.e. only gay men get AIDS, or rinsing a syringe with water is good
enough).
Numerous studies have been done to assess the level of
knowledge of AIDS in various sub-populations, including drug
injectors. As with most other sub-groups, drug injectors are
generally aware of the AIDS virus, and also know that it can be
transmitted through sharing of syringes. There are gaps in their
knowledge: Feucht (1991) reports that many are unaware AIDS can
be transmitted perinataly and many believe that an HIV positive
person looks sick.
Studies have also assessed the efficacy of different education
methods. Methods include group discussions, peer education,
lectures, videos, mass media, printed material, and one-to-one
outreach workers. Studies attempt to answer whether education
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works, which methods work best, and how long effects of education
last. For example, a study by Baker (1993) in Australia showed that
repeated interventions (6 sessions) were more effective in reducing
risky needle use behaviors than a single session.
Fisher and Fisher (1992) reviewed 48 AIDS education and
prevention studies done between 1980 and 1990. They assessed
whether the intervention was based on a formal theory, and whether
pre-tests were used to discover unique needs of specific target
groups before the intervention was done. They then reviewed the
intervention and the impact it had. They found that the most
successful interventions were based on a formal theory and used
pre-tests, the results of which were then used to design the
intervention specifically for the client population.
A study in Cleveland by Stephens (1991) assessed change in
behavior of drug injectors who were given a pretest, HIV education
and a posttest three months later. The most significant changes were
in risky needle use behaviors (sharing of syringes decreased from
67% to 24%, and cleaning with bleach increased from 34% to 62%). No
differences were found between those in treatment and those not In
treatment, or between gender or ethnic minority groups. Effects of
the intervention worked equally well for all demographic groups.
In contrast, a study by Hong and Berger (1994) showed that
different models of HIV counseling and testing programs
(confidential, anonymous, by-appointment and walk-in) attracted
different populations. It illustrated the importance of a variety of
strategies aimed at different target groups.
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Battjes (1994) looked. at differences in risk factors among drug
users in five citiels, New York, Asbury Park and Trenton in New
Jersey, Baltimore arId Chicago. Use of "speedballs" and use of
shooting ga]]~ries. were risk. factors. There were differences between
cities: in fOijr of the five cities, being African-American was a risk
factor, while in two cities being Puerto Rican was a risk factor. This
study also advocated use ofi multiple risk reduction models which
took into accpunt tlJe racial/ethnic makeup of the area, as well as
variations in social and environmental factors.
A study by IFeucht (19)91) looked at the effects of education
programs on increa;iling HIV knowledge among drug injectors, and
how long-Iast~ng th~~ effects Iwere. Drug injectors were given a pre-
test interview, and were then presented with an education program
that included lectnr~s, a fHuI and demonstrations on how to clean
syringes and \lse tl condom. I Subjects were contacted three to five
months later for ;a post-test.
Drug injectdrs showed Ia significant increase in knowledge of
AIDS. The ijighest increases were in areas directly impacting their
lives -- cleaning injection equipment. There was not a significant
decrease in know1edge between subjects receiving a three-month
post-test, and thosle receiving!, a four or five-month post test, and it
appeared that the Ieffects of I education were sustained over time.
A three··city study by Andersen (1993) also showed that
education interven1ti9ns werel effective in reducing risky behavior,
and change Wi1S sus~ained over time. Drug injectors in Baltimore,
Detroit and New Yqrk emergency rooms were given HIV prevention
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education and were also helped by nurse-counselors to increase their
sense of well-being. Clients were helpe(1 to idenltify a prImary
concern, make a plan and take action to resolve tlheir concern. Three
months later, drug injectors reported a greater sense of well-being,
reductions in IV drug use, and reductions in ~harill1g of cookers. At
SIX months after intake, these changes in be.havior were sustained.
There are also studies which call ~nto quesltion the effectiveness
of education. A study by Calsyn (1992) hypothesized that a 90-
minute AIDS education session with optional HIVi testing and
counseling would be more effective than eitQer al 90 minute
education session only or no education sttssion. Drug injectors
entering a methadone clinic in Seattle were ~ivelll an initial interview
and then randomly assigned to a 90-mir~ute sessilon, a 90-minute
session plus HIV testing, or a waiting list. Follow-up interviews were
done four months later (n=218) to assess; involvement in high risk
needle use behaviors. The sample of drug injectolrs, as a group,
significantly decreased risky behaviors. However, there were no
significant differences between groups.
This finding is supported by a study by McG:usker (1992). Drug
injectors entering short-term (21 days) trea~men~ programs were
given a short or lengthy AIDS education pro¥ram.1 The short program
consisted of two one-hour sessions, whil~~ th(/, long program consisted
of six one-hour sessions along with a 30-minute individual session,
and assistance with putting knowledge in(o practi6e. At follow up
(10 to 18 weeks later), all subjects redu~ed riskyl behaviors and had
increased their knowledge of HIV. The group reeeiving the lengthy
34
program did reduce frequency of injection significantly more than
those in the short-term program. However, there were no
differences in risky needle-use behaviors.
Possible explanations for findings of these studies include
effectiveness of media campaigns in reaching the drug injecting
population, or word-of-mouth peer education among drug injectors.
These studies do raise questions about the advisability of directing
large amounts of funding towards structured, lengthy AIDS education
sessions. It appears that simple, brief sessions may be as effective as
longer and more costly tactics.
Education programs designed to prevent HIV among drug
injectors are now in place in every major city in the United States.
These programs typically utilize on-street outreach workers to find
drug injectors rather than relying on drug injectors to come to a fixed
site. Most programs distribute both bleach and condoms as well as
give information about how the HIV virus is transmitted and how
drug injectors can protect themselves.
The largest outreach and education program targeted at drug
injectors was developed by the National Institute On Drug Abuse
(NIDA) in 1987. The program not only conductd outreach and HIV
prevention, but collected information about risky behaviors at six-
month intervals using a standardized instrument. The program is
the National AIDS Demonstration Research (NADR) project. It started
with six sites, and by 1988 had expanded to 41 sites across the
United States (including Portland). Interviews were done with
26,356 drug injectors and 5,435 of their sexual partners. The
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importance of the project is that it was the first large-scale
assessment of the characteristics and behaviors of out-of-treatment
drug; injectors.
Reports from Stephens (1993) of results from the NADR
projects were positive, showing that drug injectors reduced risky
neeqle-use behaviors over time. Reports w~re compiled from 13,475
drug injectors at 28 sites. Sharing with two or more people
decreased from 54% to 23%. Drug injectors also reduced daily drug
use between dntake and follow-up by 50% Sharing of !cookers, cotton
and rinse water decreased by 40%. Changes in sex behaviors, on the
other hand, were small, with only slight increases in every-time
conqom use.
Education is a necessary component of AIDS prevention
programs for I drug injectors, but is not the apswer to controlling the
epid~mic. The evidence from research and behavior change theories
is tQat education in and of itself is insufficient to affeclt significant
and long-lasting changes in behavior. Motivations andl beliefs must
be Gonsidered, and interventions must be targeted and made
cultllrally relevant. Education must also be complemented by easy
acce~s to drug treatment programs, and acce~s to sterile syringes so
that drug injectors not only know how to protect themselves, but
have the means to do so.
Legalizing the Sale of Syringes
An approach to help limit the spread of HIV amo:ng drug
injectors is to remove barriers to access by allowing leg1al sale of
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syringes. Currently, sale of syringes IS prohibited in ten states in the
United States. They are New York, California, New Jersey, Rhode
Island, Delaware, Illinois, Maine, Massachusetts, New Hampshire and
Pennsylvania (Gostin, 1994). Under these needle prescription laws,
syringes can only be issued upon prescription by a doctor, and must
be for an authorized use.
In addition to needle prescription laws, there are drug
paraphernalia laws in 45 states. These laws generally prohibit
anything that is used to manufacture or sell illegal drugs, and makes
it illegal to possess or use equipment to inject illegal drugs.
In Oregon, there is a statue forbidding sale or distribution of
syringes to minors. In 1989, a drug paraphernalia bill was
introduced into the Oregon State legislature which would make the
sale, distribution and possession of injection and other drug use
equipment illegal for people of any age. Outside In, a social service
agency in Portland, Oregon, lobbied hard against this bill as this
agency was about to open the Needle Exchange Program. The
legislature passed the bill, but made an exemption for syringes,
making this a unique drug paraphernalia law.
The rationale behind drug paraphernalia and needle
prescription laws is much the same as the rationale behind laws
making drugs illegal. Making ejection equipment illegal will make it
more difficult to obtain, and will result in fewer people using it.
People may also refrain from obtaining it from fear of getting caught
and legal consequences. Such laws also give a strong moral message
to drug injectors that such behavior is not socially acceptable.
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However, these drug control policies are in direct conflict with
public health policies, and it has been demonstrated by Connecticut
that relaxing restrictive needl~ laws has a public health benefit.
Connecticut passed a law in 1992 (in response to the AIDS epidemic)
that allowed pharmacists to sell up to ten syringes to customers. The
law also allowed individuals tl,) possess up to ten syringes. An
evaluation by Groseclose (1994) was conducted for one year
following the change in the la.w. The study found that knowledge of
the law among drug injectors increased steadily, and at nine months
over two-thirds were aware of thel new law. Sale of syringes by
pharmacies also increased steqdily' over the year. Drug injectors
reported purchasing the majority ~ of their equipment from
pharmacies rather than from street sources, and reported a reduction
In sharing of syringes.
Needle prescription and drug paraphernalia laws do result in a
scarcity of sterile syringes av~ilable to drug injectors, and therefore
lead to sharing of injection equipment (Gostin, 1994). Given the
public health goal of reducing the I spread of HIV among this target
group, a harm reduction mod~~l iSI more appropriate than laws
limiting the supply of syringes.
RESPONSE OF THE FEDERAL GO'VERNMENT TO NEEDLE EXCHANGE
Starting in 1988, the fet;lerall government of the United States
passed five laws prohibiting use of federal funds for needle exchange
programs. These laws were passe:d during President George Bush's
administration. They have nqt been repealed (as expected) under
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President Clinton's administration, despite recommendations to do so
from various commissions and agencies assigned to study the issue.
The United States General Accounting Office (1993) reviewed federal
bans:
The first ban on use of federal funds for needle exchange was
attached to the Comprehensive Alcohol Abuse, Drug Abuse, and
Mental Health Amendments Act of 1988 (later repealed in 1992).
States could not receive block grants under this act unless they
agreed not to use funds "to carry out any programs of distributing
sterile needles for the hypodermic injection of any illegal drug or
distributing bleach for the purpose of cleansing needles for such
hypodermic injection .... "
The Health Omnibus Programs Extension of 1988 funds both
AIDS services and HIV education and prevention programs in this
country. This act states that:
None of the funds provided under this Act or an
amendment made by this Act shall be used to provide
individuals with hypodermic needles or syringes so that
such individuals may use illegal drugs, unless the
Surgeon General of the Public Health Service determines
that a demonstration needle exchange program would be
effective in reducing drug abuse and the risk that the
public will become infected with the etiologic agent for
acquired immune deficiency syndrome.
The Ryan White Comprehensive AIDS Resources Emergency Act
of 1990 also funds both services for people with AIDS and HIV
education and prevention programs. This act states that funds
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cannot be used: "to provide individuals with hypodermic needles or
syringes so tbat such individijals may use illegal drugs."
The Departments of Labor, Healthl and Human Services and
Education, an(I Related Agenqies Appropriations Acts of 1990 and
1991 state th,at:
None of thie funds appropriated under this Act shall be
used to carry out any program of distributing sterile
needles for the hypoder;mic injection of any illegal drug
unless tpe President of the United! States certifies that
such prqgrams are effeqtive in stopping the spread of
HIV an~ do not encourage the usel of illegal drugs.
Finally, the Departments of Labor,1 Health and Human Services,
and Education~ and Related Agencies Appropriation Act of 1993
states that:
Notwithstanding any other provIsion of this Act, no
funds appropriated under this Act shall be used to carry
out any proglram of dis~ributing slterile needles for the
hypoderrnic ifljection of any illegal drug unless the
Surgeon General of the United States determines that
such prqgram:s are effeotive in preventing the spread of
HIV and do inot encourage the usel of illegal drugs, except
that such funds may be used for such purposes in
furtherance of demonstrations or Istudies authorized in
the ADAMHA Reorganization Act. I
There h('Jve been a number of reports and commissions that
have urged th~ fed,eral government to lift the bans on federal
funding for needle lexchange programs. IThe National Commission on
AIDS was crellted to advise the Presiderlt of the United States and
Congress on AIDS policy. In 1991, this Commission recognized needle
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exchange programs as an important AIDS prevention tactic, and
called for lifting federal bans on funding for such programs.
The General Accounting Office of the United States (1993) was
asked to review the data on needle exchange programs and assess
whether federal funds could be used for them. This request came
from the House of Representatives Select Committee on Narcotics
Abuse and Control. They concluded that "needle exchange programs
may hold some promise as an AIDS prevention strategy," but that
current federal laws prohibited federal funds from being used to
support them.
In the fall of 1993, a panel on needle exchange and bleach
distribution met in Baltimore, Maryland. This panel was convened
by the National Research Council. Members of the National Research
Council are drawn from the National Academy of Sciences, the
National Academy of Engineering, and the Institute of Medicine, all
advisory groups to the federal government. Outside In's Needle
Exchange Program was invited to participate on the panel. The
recommendation of the panel facilitator was that there ought to be
state and federal funding of needle exchange programs, both because
this country does not have a comprehensive plan for HIV prevention
among drug injectors, and because such programs could also reduce
the prevalence of other diseases such as tuberculosis (Moss, 1994).
Also in 1993, Centers for Disease Control commissioned Dr.
Peter Lurie at University of California, San Francisco to review needle
exchange programs in the United States, assess both positive and
negative effects, and make recommendations. Again, Outside In's
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program was included in the review. Dr. Lurie (1994) also
recommended that the ban on use of federal funds for needle
exchange programs be lifted: "The federal government should repeal
the ban on the use of federal funds for needle exchange services and
substantial federal funds should be committed both to providing
needle exchange services and to expanding research into these
programs. "
While the report reviewing needle exchange programs was
released, the review of methods, findings and recommendations was
not allowed to be released by the Public Health Services Assistant
Secretary for Health. In December 1994, the San Francisco Chronicle
published an article titled "Public Health Malpractice. Needle-Swap
Report Being Kept Secret," accusing the Clinton administration of
covering up the report which recommends funding needle exchange
programs to help prevent the spread of AIDS.
Locally, on November 20, 1994, the Oregonian newspaper
published an editorial urging Congress to support needle exchange
programs and lift the ban on federal funding. The editorial stated
that needle exchange programs "have proved their worth," both in
reducing the spread of the virus and in facilitating drug injectors
entering treatment programs.
Despite the recommendations of these vanous reviews and
reports, laws prohibiting use of federal funds for needle exchange
remain in place. There is currently little optimism that these laws
will be revised in the immediate future.
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RATlONALE FOR A HARM REDUCTION MODEL AND SYRINGE
EXCHANGE
Rationale for la Harm Reduction Model
The harm reduction model as it relates to drug use originated
In the Netherlands in the early 1980's. At that time the Dutch
implemented needle exchange programs to help drug injectors
protect th~mse:lves against hepatitis B infections. The goal of a harm
reduction model is to minimize the destructive effects of drug use for
both the i;ndivlidual and for society. The objective, then, is not
necessarily to eliminate risky and destructive behaviors, but to
minimize or neduce them to the extent possible.
The approach of government in the United States has been to
declare a "waJr on drugs," start a "just say no" campaign, and advocate
a treatmen.t and abstinence only approach to drug use. It has not
been highly effective.
Rather than a rigid approach that will not work with or offer
services tQ drug injectors until and unless they express a willingness
to stop using I drugs, a harm reduction approach offers perhaps a
more hum\lne land realistic approach. It recognizes that use of drugs
and risky beh:aviors lie on a continuum, with the most destructive
behaviors at one end and abstinence at the other. It works with
people no maHer where they are on the continuum, and helps them
move down towards less destructive behavior one step at a time.
Such a model supports and reinforces positive change. It does
not judge peolple as expendable or not worth serving because of
illegal dru~ uSje. It works to maximize the well-being of the
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individual, helping them to manage their drug use and health to the
extent possible. It is a concept that is not widely accepted in this
country, that is, that people currently injecting drugs can and should
be helped to make life-enhancing choices.
Needle exchange programs do not insist clients be involved in
treatment. Rather, the approach is that if people are committed to
using drugs, then it is better for them to use injection techniques that
do not expose them to HIV, Hepatitis B and other diseases. Entry into
treatment is a desirable outcome, but not the only one.
Rationale for Syringe Exchange
Throughout the 1990's, drug injectors will continue to be at
high risk for HIV in the United States. Syringe exchange programs
increase the supply of sterile syringes among this population,
attempting to reduce sharing of syringes and therefore the
transmission of HIV. In addition, by providing safe disposal of used
syringes, exchanges prevent possibly contaminated needles from
being left in public places where others might be accidentally stuck.
Exchanges can also provide access to a traditionally difficult-to-reach
group, establishing contact between public health staff and drug
injectors, contributing to drug and sex risk reduction and acting as a
bridge to drug treatment.
While education efforts, bleach distribution and drug treatment
slots should be expanded, and should be integral parts of any AIDS
prevention program directed towards drug injectors, they are
unlikely to provide an adequate solution by themselves. And given
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that the goal of eliminating injecting drug use is not likely to occur
soon, other prevention measures must be considered.
Needle exchange programs fit well into the harm reduction
model. They do not insist on abstinence, but make sterile needles
available to reduce sha.dng of syringes and transmission of AIDS. If
clients continue to share, they are counseled to clean equipment with
bleach before doing so. They are helped to use not only sterile
syringes, but sterile injection procedures. In addition, most needle
exchange programs view themselves as reaching a difficult-to-reach
population, building trust, educating clients about treatment options,
and facilitating entry into treatment programs.
Giving sterile injection equipment to drug injectors is
controversial in this country. Proponents hope needle exchange
programs will prevent drug injectors from contracting HIV without
increasing drug use or the number of drug users. Opponents of
needle exchange programs assert that such programs are enabling,
"give the wrong message," and promote and condone drug use. This
study was conducted to assess the extent to which a needle exchange
program accomplished what its proponents hoped it would, and the
extent to which it fulfilled the fears of its opponents.
BACKGROUND OF THE EXCHANGE
STARTING THE EXCHANGE
In 1987, Outside In planned to open a needle exchange
program. The rationale for the program was to help protect clients of
the agen1cy from HIV. Clients included those using the medic;al and
prenatal care clinics at the agency (people of all ages), and hiomeless
youth clients.
Clients of the clinics sometimes had a history of injection drug
use, or had been partners of drug injectors. Also of concern :were
homeless youth clients. Outside In sees approximately 1,0001 such
youth annually in its Homeless Youth Program. Th~se youth: are at
high risk for HIV infection. Approximately 30% idctntify as g:,ay,
lesbian, !bisexual or undecided. Many are involved in prostitilItion as
a means of survival or experimentation, and few use safer sex
practices consistently. Whether or not they are invqlved in
prostitution, they generally have multiple sex partn~rs. As
adolescents, they often feel invulnerable, and are ~xperiment:ing with
risky behaviors. As homeless adolescents, they are usually fiocused
on the immediacy of their survival needs -- where ~hey are going to
sleep that night and on what is going to happen to them over the
next few weeks or months. A virus that might not affect them for
many years is not often a priority in their lives. Fir/ally, at least 90%
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of these homeless youth use alcohol and/or drugs, and many inject
drugs.
Each year 30-40% of the fifty youth in Outside In's Transitional
Housing Program report a history of drug injection. The youth in this
program are the highest functioning and most motivated of the 1,000
youth using the agency. It is likely that a higher percent of youth
among the general population of street youth have a history of
injection drug use.
Injection drug use habits among homeless youth are somewhat
different than those of adult drug injectors. Youth are of course less
likely to have long histories of serious drug use. In fact, at that stage
in their development, they are experimenting around with many
behaviors, and for many, injecting drugs is simply one such
experiment. Youth, then, tend to inject more sporadically than
adults, and often in party situations. This also means, however, that
they are less likely to plan ahead and carry new syringes or bleach
to clean syringes, and are likely to share injection equipment.
Because of the vulnerability of Outside In's clients to HIV, the
agency felt some responsibility to try to protect clients from this
disease. The agency first decided to simply give syringes to clients
who wanted them.
Outside In decided to open a needle exchange program. When
this was proposed, it was to be the first such program in the United
States. Outside In decided, therefore, that it was important not only
to provide the service, but if at all possible to connect it to a strong
research component to evaluate the effects of this new public policy
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and program to prevent HIV among drug injectors. The American
Foun~ation for AIDS Research granted funding for the program and
the evalu8ltiqn for two years.
The start of the program was delayed for two years becall\se of
probl~ms obtaining liability insurance for the program. Finally, the
Multr~omah County Board of Commissioners and Health Department
grant~d Outside In additional funds to obtain needed insuranc1e and
to supplement the research. The program then opened Nqvember 1,
1989.
LEGALITIES
At the time thle Needle Exchange Program began in 1989, there
were no dru~ paraphernalia laws in the State of Oregon. Then~ was,
however, :an Oregon statute (passed in 1993) prohibiting rninor~;
(under age: l8) from being given a syringe unless the mmQr
demonstrated a lawfUlI need and it was authorized by a physicilm,
parent, legal guardian or other acceptable alternative.
This was a dis:appointment to Outside In as almost half olf the
homeless YO\lth seen in its Youth Program were under age 18. ! Part
of th~~ rationale for starting a needle exchange program at Outside In
was the high vulneralbility of homeless youth to HIV infection. ,
Outsi~le In wished to make syringe exchange available to all
homeless yOl,lth, not just those over age 18. The AIDS vim;') dia not
discri;minate between a sixteen year-old and an eighteen year:·qld,
"
and we did not want to either. However, the agency's pro~ran~~ must
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operate within the law, and our policy, therefore, was to accept only
those clients into the Exchange who were age eighteen or older.
In 1989 a drug paraphernalia bill, Senate Bill 464, was
introduced into the Oregon State Legislature. Outside In lobbied hard
to keep syringes legal in the state. Outside In also argued that
passage of the bill would prevent the proposed needle exchange and
research project from opening. In the end the bill was passed, but
with an exemption for syringes. It is illegal to possess drug
paraphernalia in Oregon other than syringes -- making this one of
the oddest drug paraphernalia laws in the United States.
POLITICAL CLIMATE
Nationally, the position of the federal government under
Presidents Reagan and Bush was one of opposition to needle
exchange programs. Locally, reactions to Outside In's proposed
Needle Exchange Program were primarily, although not entirely,
positive or neutral.
When planning for the program, Outside In approached its
funding sources, including the county and United Way, to inform
them of its plans. We also approached Outside In's landlord, the First
Unitarian Church to obtain their approval. They were all supportive.
Outside In asked the Oregonian to write a story on the
proposed needle exchange program. A story appeared in the
Oregonian February 14, 1988. Neither Outside In nor the Oregonian
received a single letter or phone call about the article.
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Outside In formally announced in May 1988 that it had
obtained funding and was opening the first needle exchang~ program
in the United States. Outside In requested county health department
officials to participate in the press conference. They agreed, but I at
the last moment canceled. The Chair of the Board of County
Commissioners did not want the county to be that closely affiliated
with the potentially controversial program. Both the state C'/nd
county health departments stated to the press that the efficqcy of
needle exchange programs was unproven. However, becaus~ there is
no vaccine or cure for AIDS, they supported research on all poteilltial
interventions and therefore welcomed the planned research project.
The county stated they were granting money for insurance C'/nd to
supplement the research. Both state and county health departmlents
publicly offered technical assistance to Outside In.
The chief of police at the time the Exchange opened w(~s
personally opposed to needle exchange programs. However, the I
public position of the police department was that they saw no reason
to take a stand either way on the issue as it was not a legal matter In
Portland. The police department spokesperson added that he
welcomed AIDS prevention programs. The last two chiefs of polilce In
Portland have been supportive of Outside In's Needle Exchange
Program.
The then mayor of Portland, Mayor Bud Clark initially was
quoted in the paper as saying he was worried about the ima~e of
Portland, given the national attention Outside In's proposed program
was receIvIng. I called the mayor's office and expressed my concern
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that the police department was more supportive than the mayor's
office, and was told he was misquoted. The governor of Oregon, Neil
Goldschmidt was asked on television what he thoughl of I the Needle
Exchange Program, and he was fairly supportive, stating I that he
regretted the necessity for such programs, but they did seem
necessary.
Both local newspapers, the daily Oregonian and th~ weekly
Willamette Week, published editorials in support of Outside In's
Needle Exchange Program. After almost a year of d~lays~ the
Oregonian published a second editorial (March 31, 1989) again
endorsing the Exchange and stating that if Outside In could not begin
the program, "the County should do so -- and quickly."
Opposition came from three major sources: the Lyndon
LaRouche group, the Oregon Citizen's Alliance, and Mr. Jeffery
Kushner, Assistant Director of the State Alcohol and prug Division.
The Lyndon LaRouche group picketed Outside In for two I hours and
called a press conference in front of Outside In. Probably because of
their style of operating, their picket was not taken s~rioulsly by the
press or general public. Our main concern was keeping slOme of our
homeless youth clients from defending us and gettin~ into
confrontations with them.
The Oregon Citizen's Alliance (OCA) publicly st.ated on television
that they were opposed to the Exchange. They are a right-wing
organization who have been centrally involved in efforts to pass
discriminatory legislation against gay men and lesbia~ls in Oregon.
Outside In opposes them as much as they oppose us.
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Mr. Kushner also stated on television and in public meetings his
opposition to needle exchange programs. He said that his position
was the position of the state. According to potential funding sources
of the Exchange, he contacted them and requested that they not fund
Outside In. Finally, he sent a letter to the federal government
regarding a grant we had submitted for housing for homeless youth
and stated that it
interfered with the objectives of his office. I called the governor's
office to get a ",:ritten retraction sent, and to get Mr. Kushner to stop
contacting potential funding sources of the Exchange. (We then
received the federal housing grant).
MEfHODS
LOCATION OF TIlE EXCHANGE
The Needle Exchange Program was begun at a fix<;d sHe at:
Outside In. Outside In is a social service agency in downtown
Portland, serving low-income adults and homeless youtlJ since 11968.
Current programs operated by the agency include primary and
prenatal care clinics serving low-income people of all ages who liack
health insurance, and a youth program serving homele~is youth I
under the age of twenty-one. The youth program includes a
seventeen-bed transitional housing program, a drop-in center, c,ase
management, mental health treatment, access to emerge;.ncy foodi and
shelter, an employment training and work experience program, ;an
education program that helps youth obtain GED's and tlJen attend
college free (a local community college waives tuition), i1 HIV pe,er
education group and services for gay, lesbian and bisex;ual homeless
youth.
Locating the Needle Exchange Program at Outside In was n:ot
ideal. First, the agency is not located in an area which ~s he;avily
frequented by drug injectors. It was not known if many drug
injectors would go out of their way to go to Outside In to ge:,t sterile
syringes, especially since they are legally available over-tbe-coumter
in Oregon.
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Second, Outside In is located across a highway, one block from
a public high school. It was thought there may be concerl'jS about
students having easier access to syringes.
Finally, Outside In is primarily a youth agency, serving
approximately one thousand homeless youth annually. Again, we I
were worried about concerns that the Needle Exchange Program
ought not to be operated at an agency serving primarily youth.
However, locating the Exchange at a location other tijan Outside
In was also problematic. First, no one wanted such a program in
their neighborhood, and in fact we were sure to encounter strong
opposition if we tried to re-locate it.
Second, the program was minimally funded. If we rented
space elsewhere, we would need funds for the additional ~'ent,
utilities, telephone, reception and security. We were unlik~~ly to be
able to raise these funds.
It was decided to site the program at Outside In. In many
ways, the location was good. Outside In is located in downtown
Portland, on a bus line. It is on the corner of Thirteenth Avenue and
Salmon Street. Our neighbor across Thirteenth Avenue is ~ freeway.
Our neighbor across Salmon Street is a parking lot. Our immediate
neighbors sharing our block are a small delicatessen and the First
Unitarian Church of Portland. The church is Outside In's lllndlord,
and in fact owns the entire block on which the agency is situated.
We had the full support of the church. The person renting the smaU
delicatessan rented it with the knowledge that Outside In was his
neighbor, and made no objection to the proposed program.
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CLIENT PROCEDURES
At the first visit, Exchange staff explained the research project
to clients, and asked if they wished to participate. They were told
they would be paid for their time. If clients volunteered for the
research component, they were given an informed consent form to
read and sign, and an interviewer was called to administer the
questionnaire. The interviewer went over the informed consent
form with the client, making sure it was understood and then signed.
The interviewer then administered a survey wiJ: h took
approximately one hour. At the end of each interview, each client
was asked a series of questions to test their knowledge of HIV/AIDS,
giving staff an opportunity to provide HIV education. Following the
interview, the client was taken back to the staff person conducting
the needle exchange. HIV pre-test counseling was provided and
blood drawn for HIV and Hepatitis B tests. The client was paid for
his or her time, and requested to return within three months for a
follow-up interview.
To respond to concerns about youth, special attempts were
made to prevent youth younger than age eighteen from using the
program. Identification was checked if the age was in question, and
if the person lacked identification, they were sent to the Social
Security Office (three blocks away) for a printout of their social
security number which they could get that same day.
The fears that drug injectors would not go out of their way to
come to Outside In to use the Exchange proved to be unfounded. In
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fact, some clients told us that they prekrred to come to Outside In
rather than have us rent a storefront elsewhere for the Exchange.
They weren't necessarily identified as a drug injector by using the
Exchange at Outside In: someone watching them go in wouldn't know
if they were using the Exchange or the medical clinic.
STAFRNG THE EXCHANGE
I recruited a man to staff the Needle Exchange Program who is
a registered nurse and very knowledgeable about HIV. In fact, he
was a trainer for Cascade AIDS Project, the county's largest local
AIDS organization. He had been a volunteer nurse in Outside In's
clinic for years, and served briefly on the agency's Board of Directors.
He is a compassionate and thoughtful man.
Because the Exchange was minimally funded and the salary
rate quite low -- especially for a nurse, he preferred to work part-
timeat the Exchange, and keep his job at the hospital part-time. I
placed an employment ad, and hired two additional staff -- a woman
for twenty-five hours per week, and a man for fifteen hours per
week. The woman had worked with low-income people in outpatient
community clinics and had experience drawing blood, and the man
was a Family Nurse Practitioner who had recently graduated from
Yale and who had a strong interest in working at the Exchange. The
final staff member was an African-American woman already on staff
full-time at Outside In. She expressed interest in working in the
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Excha~lge, and was released from her regular duties six hours per
week to do so.
There were co-principal investigators for the study. One was
Direct9r of Research at the Chemical Dependency Institute at Beth
Israel Medical Oenter and Deputy Director for AIDS Research at
Narcotic and Drug Research, Inc. in New York. The other was an
Associate Professor at Portland State University.
PROGRAM PROTOCOLS
The hours 'of the Exchange were 3pm to 7pm Monday through
Friday. A small room opening off the lobby was set aside for the
progra~n. Drug injectors were taken one at a time into this room to
conduot the exchange. This allowed for privacy and gave staff an
Opport\lnity to provide one-on-one education and counseling.
In order to be eligible to exchange syringes, potential clients
had to prove the,y were drug injectors and were over the age of
sevent~en. The Ifirst requirement was to allay fears of those who
didn't want us giving syringes to people who wanted to start
injectirlg, particularly students from the near-by high school. The
second requirement was in response to an Oregon statute prohibiting
anyone from distributing syringes to minors. To satisfy the first
requirement, we lasked potential clients to show us identifiable
needle marks (at the first visit only). To satisfy the second
requirement, clients whose age we questioned were asked to show
identification.
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At the first visit, clients were given three syringes, whether or
not they brought any in. The program was explained to them, and
they were told thereafter they could exchange up to ten syringes per
visit. Over the next several years, Outside In experimented with the
number of syringes issued from this low of ten per visit to no limit at
all. The original limit of ten was established in response to people In
the community who wanted us to have a low limit. However, it
discouraged people who had to travel a distance to the Exchange: if
they were heavy users, they had to come two or three times per
week. When Outside In issued an unlimited number of syringes, it
soon became apparent that we were supporting a number of small
businesses dealers who got them free from us and then sold them
or the use of them. In addition, Outside In's Board of Directors and I
felt that a major value of the Exchange was the continuing contact
between Exchange staff and drug injecting clients, and the
opportunities this afforded staff to provide counseling and education.
Currently, drug injectors are allowed to exchange up to forty syringes
per week. Exchange staff are allowed some discretion in enforcing
this policy.
At the first visit, an identification number was generated by
and for the client. This both allowed clients to remain anonymous
and allowed Outside In to track clients for purposes of collecting data
-- both of critical importance. The client generated their own client
number each time they came in by giving the same information to
staff.
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At the first visit, the research project was explained to the
client, and they were asked whether they wanted to participate.
They were offered an HIV te~t whether or not they participated in
the research project. They w~re told about the medical services
available to them at the on-sit~ clinic. I They were given referrals to
other services, including drug treatment, as they requested or were
open to hearing about them. Finally, they were requested not to
shoot up within four blocks of Outside :In, in the interest of
maintaining good neighborhood relations.
Drug injectors were given not on1ly sterile syringes, but
everything they needed for sterile injections. This included small
bottles of bleach with instructions for use printed on them, small
bottles of distilled water, a choice of cdtton balls or cue tips, and
alcohol swabs. We gave out bottle caps to be used as cookers until
we had to discontinue this as we were ,in violation of the new drug
paraphernalia law. We also gilve out condoms and a handout which
explained the proper way of using them and of cleaning syringes.
Finally, we distributed matchbqoks with the hours of operation of the
Exchange and a prevention mf!ssage ("You wouldn't share your
condom, so why share your syringe?").
At first, we prepackaged all of thlis and put the items either in
brown paper bags or in large ~oft drink cups (with lids). However,
because some drug injectors wanted mme distilled water, and others
didn't want condoms etc., and we felt al lot of material was simply
being discarded, we set up wh(~t we called "the salad bar of
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prevention." We set everything out in bins and simply allowed the
clients to select what they wanted.
Exchange staff were instructed not to handle syringes returned
to the program by clients. Outside In has large sharps containers in
the Exchange room. Clients are asked to put their syringes in the
containers one by one, and staff count the syringes as they do so.
The number brought in is the number of sterile syringes they are
given (other than the first visit) up to the set limit. When the sharps
containers are full, Outside In pays a medical waste disposal
company to pick them up and dispose of them in accordance with
Oregon's infectious waste disposal regulations.
RECRUITMENT OF SUBJECTS
The two groups of subjects participating in the study were drug
injectors using the Needle Exchange Program, and drug injectors not
using the Exchange. Drug injectors using the Exchange were
recruited primarily by word-of-mouth. Outside In did little
advertising to attract clients. However, the opening of the Exchange
was reported on the network television stations, many radio stations
and in the Oregonian. The Exchange was the subject of various talk
shows on both television and radio stations. Follow-up stories were
also reported periodically in the media.
Outside In did hand out both matchbooks and business cards.
Both had the address and hours of the Exchange. These were
distributed to clients both as reminders to themselves and to give to
friends.
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Once clients came to the Exchange, were determined to be
eligible, and their syringes exchanged, they werle informed of the
study. They were told why we were doing the study, what would be
expected of them if they chose to participate, and that they would be
paid for their time. They were then asked if they wished to
volunteer. If subjects were obviously under th~ influence, they were
not allowed to participate at that time;., but were requested to return
the following day for their interview.
COMPARISON GROUP
Drug injectors not using a needle exchange program were
recruited by the Multnomah County H~alth Divi$ion. The health
division was participating in a national survey of drug injectors
funded by the National Institute on Dnlg Abuse I(NIDA). The county
hired outreach workers to do on-stree~ outreach in various
neighborhoods in Portland to find dru~ injectors and conduct the
surveys. The county also placed posters in social service agencies to
recruit subjects.
The state and county health divisions agreed to share data with
Outside In. The same instruments were used for both projects, and
the same trainer (on staff at Multnom;ah County) trained initial
interviewers for both.
Clients in the county outreach p\'oject were those who had
injected drugs during the past six months, and who had not been in
drug treatment programs during the past 30 days. Clients were
either given bleach and minimal HIV prevention education, or given
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bleach and then assigned to a group for more extensive education
and counseling. Because there were no significant differences in
changes in behavior between the two groups over time, drug
injectors from both groups were included in the data set given to
Outside In.
An important difference between drug injectors usmg the
Exchange and those using the outreach project is that locator
information was collected from clients in the outreach project, while
clients using the Exchange were allowed to remain anonymous. The
Exchange was unable to contact clients for follow-up, and depended
on clients remembering to come in. It also may have had an effect
on clients self-selecting for the two projects, depending on how
comfortable they were with giving detailed locator information on
themselves.
Drug injectors selected by the county for comparison with the
Exchange subjects were those who had been interviewed after
11/1/89 (the date the Needle Exchange Program began). They also
were clients who were still injecting at the six-month data collection
point, to make them more comparable to Exchange subjects. As with
Exchange clients, they were not included if the interviewer judged
their interview to be unreliable. Finally, both programs excluded
clients who had already been interviewed by the other program.
SURJECf FEES
Subject fees for clients of the Needle Exchange Program were
initially set at $11 per interview. Checks were given, not cash, as we
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did not want to keep supplies of cash at the agency. The fee was
actually $10, with an extra dollar to pay the fee at check-cashing
services.
Within two months the Needle Exchange Program had large
numbers of people coming simply for the money. So many came in
fact, that Outside In had to set up an overflow lobby in the back of
the building. It was becoming disruptive to the other agency
programs. In addition, people began to scam us, coming back
repeatedly and giving a different identification number each time.
We decided this was a misuse of the program, and in February
decreased subject fees from $11 to $5 for the initial interview. We
retained the fee of $10 for follow-up interviews to encourage return
visits. A near-by Fred Meyer grocery store agreed to cash Outside In
checks for clients without charging a fee. The reduced fees solved
the problems, and the number of clients scamming or coming simply
for the money decreased dramatically.
Subject fees for drug injectors participating ll1 the county
outreach project were $20 per interview for both initial and follow-
up interviews.
CLIENT INTERVIEWS
Needle Exchange clients participating in the research
component were surveyed at three month intervals. Clients were not
given surveys to fill out themselves, but rather the survey was
administered by a trained interviewer. All questionnaires took an
average of one hour to administer.
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An initial interview was conducted at the first visit, and clients
were requested to return every three months for follow-up
interviews. Because locator or tracer information was not collected
on clients (and in fact they were allowed to remain anonymous), it
was necessary to depend on clients remembering to return at the
right time. If a client was a regular user of the Exchange, staff could
remind them to interview every three months. For other clients, this
was not possible. In order to collect as much data as possible, clients
were allowed to participate In the surveys if they came as early as
two weeks before their interview due date, or two weeks after.
The majority of the questionnaires were administered to clients
by volunteer students from a class in Community Psychology at
Portland State University. This class was a year-long senior and
graduate-level class. Surveys were also administered by the class
instructor, by Needle Exchange staff, by a few other Outside In staff
and by myself.
INSTRUMENTS
Outside In used the questionnaires designed by the National
Institute on Drug Abuse (NIDA) for use in its National AIDS
Demonstration Research (NADR) project, a national survey of drug
injectors. They were used because they were the instruments used
by the county's survey of drug injectors from which the comparison
group for our study would be drawn. Because the NADR survey was
conducted in a number of cities across the United States, it would
also be possible to compare clients of the Exchange with drug
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injectors in other cities if desired. Agreements were made between
Outside In and the Oregon State Health Division to share data.
The AlA and AFA were constructed without being based on
theory. Behavior change models, therefore, were not part of the
design. It was necessary for Outside In to use these questionnaires
in order to compare data with the county health division.
An agreement was also made between Outside In and the local
NADR outreach project to add a screening question to all surveys.
Because we wanted to compare drug injectors using the Exchange
with drug injectors not using the Exchange, we wanted to screen out
people who participated in the NADR outreach project and had used
the Exchange. County outreach workers therefore asked survey
participants if they had ever used the Exchange, and Exchange staff
asked clients if they had ever taken the survey previously. All
clients were assured their answer would have no effect on whether
they could participate at present.
The questionnaire administered at intake was called the AIDS
Initial Assessment Questionnaire (AlA). It collected basic
demographics, history of alcohol and drug use, injection habits, use of
treatment programs, arrest records and prison history, health status
and history of previous HIV tests. Extensive and detailed questions
were asked about needle use behaviors and sexual practices over the
prior six months. Finally, an AIDS quiz was given to assess the
extent of the clients knowledge about HIV.
The follow-up questionnaires administered every SIX months
after the intake interview were Follow-Up Assessment
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Questionnaires (AFA), and were also designed by NIDA. They asked
detailed questions about drug use, needle use behavior, and sexuall
practices over the prior six-month period.
The questionnaires administered at three month intervals
between the AlA and AFA were designed for the Portla~ld Exchange
by Dr. Maynard and myself. This questionnaire was a s~b-set of
questions from the AFA. Outside In added questions to ~II the
surveys regarding use of tobacco and caffeine, and abol\t veteran
status.
Initial training in administering the questionnaire was
provided free to Outside In by the Multnomah County Health
Division. The same person who trained county outreach workers to
give the survey trained Outside In staff. This helped ensure that
staff of both projects had the same understanding of the AlA and
AFA, and administered them in similar ways. Once Dr. Maynard h;ad
been trained, he in turn trained volunteers from his Co~nmunity
Psychology class.
In order to collect data on all clients, (including the 33% not
participating in the research component), all clients were asked to fill
out a simple one-page form at every visit. This questionnaire asked
how clients had found out about the program, how far they traveled
to get to the Exchange, and brief questions about drug w~e, needle :
use behaviors and sexual practices.
In addition to the questionnaires, a daily log was ~ept by
Exchange staff. They recorded the number of new c1ientli, the
number of return visits, the number who joined the res~~arch
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component, the: number of synnges issued to each client, and the
number of pyringes returned by each client.
BLOOD TESTS
Blood wa.s drawn from study participants at three-month
intervals, at the time the surveys were administered. Blood was
tested at th{l, Oregon State Health Division Laboratory for HIV
antibodies and Hepatitis B antibodies. The initial HIV test was the
ELISA test. If reactive on three ELISA tests, samples were further
tested by the IFA test.
The «epatitis B test told us whether clients had been infected
In the past two years, not whether they were currently contagious.
Although H~paHtis B can lead to death, most people recover and then
seroconvert back to a non-contagious state. Some people will remain
contagious for the rest of their lives and are considered carriers for
the virus. ~~egardless of contagion, all people infected will continue
to test posit~ve Ion a Hepatitis B antibody test for one to two years.
Hepatitis B tests were done because we knew that we were
unlikely to be able to detect a change in the rate of HIV transmission
among subje;.cts, given the low seroprevelence rate among drug
injectors in portland (4%). A measure of Hepatitis B antibodies is a
good indicator of whether subjects are practicing the same risky
behaviors tbl'lt would lead to HIV infection, given that both diseases
are transmiqed Ithrough unsafe sex practices or sharing of
contaminated injection equipment. Hepatitis B is slightly easier to
transmit than is: HIV.
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The county outreach project originally intended to also test for
HIV. However, it was not feasible for outreach workers to draw
blood on the streets or at the various places they did outreach. They
referred drug injectors to the County Health Division for testing.
However, less than 10% followed through and obtained the test.
TRACKING DATA WHILEPROTECfING CLIENT ANONYMITY
There is usually some tension between the needs of programs
and the needs of research. In the Needle Exchange Program, the
major tension was over the need of the research component to track
data on clients over time, and the need of the program to not only
protect client confidentiality, but to ensure clients could be truly
anonymous.
This problem was solved by means of the client-generated
identification number described above. Each time clients came to the
Exchange, they gave staff information which allowed staff to
generate their number. This allowed Outside In to keep charts on
clients and connect questionnaires uniquely to each individual, and
at the same time allowed clients to remain anonymous. Clients were
asked to sign an Informed Consent Form. However a system of
witnessing the signing of this form by staff allowed clients who
refused to give their names to simply make a mark. These forms
were not placed in clients charts, but were stored at an off-site
location.
While anonymity encouraged use of the Exchange, it limited
active follow-up of clients. Outside In was dependent on clients
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remembering on their own to return every three months for follow-
up interviews. Regular users of the Exchange could be reminded by
staff when it was time for a follow-up interview, but non-regular
users were unable to be contacted.
Follow-up of clients was a difference between the Exchange
and the county NIDA outreach project. The outreach project did
collect names and locator information on clients (addresses, phone
numbers, and a friend likely to be able to contact them). This
allowed the county to find and remind clients when it was time for
follow-up interviews, but also created a possible difference between
the comparison groups.
SUB-STUDY ON DISCARDED SYRINGES
On July 15, 1989, three and one-half months prior to the
opening of the Exchange, the Project Director began daily to count
(and collect) syringes in the vicinity of the Needle Exchange Program
to provide baseline data. The search was conducted along a fixed
route within a two block radius of Outside In, three to five times per
week. Syringes found were carefully picked up and placed in sharps
containers and disposed of in accordance with Oregon's infectious
waste disposal regulations. (Parts of syringes such as a syringe cap
or part of a plunger only, which would not be exchangeable for whole
syringes, were not included in this study). Syringes were
occasionally found by other Outside In staff. If they were found
within the two block radius used for the daily search, they were
included in the study.
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The search for syringes was continued after the Exchange
opened, and ended two years after it was begun, on June 30, 1991.
The average number of syringes found per day before the opening of
the Exchange was compared to the average number of syringes found
per day after the Exchange opened.
RESULTS
RESEARCH QUESTIONS
As mentioned in the introduction, several research questions
guided this study. These questions were as follows:
1. Will drug injectors use a needle exchange program in a state
where syringes are legally available over-the-counter?
2. Will drug injectors using a needle exchange program decrease
risky needle use behaviors?
3. Will frequent users of a needle exchange program change risk
behaviors more or less than infrequent users of an exchange?
4. Will drug injectors using a needle exchange program change
risk behaviors more or less than a comparison group of drug
injectors not using a needle exchange program?
5. Does a needle exchange program have an impact on the
community in terms of a change in the number of discarded
syringes on the streets?
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Two additional research qllestiolns were posed at the beginning
of the study, but were unable tQ be ,adequately evaluated. They
were:
6. To evaluate differences in the rate of spread of HIV infection
among users and non-users of the Needle Exchange Program.
This question was raised because the ultimate objective of
exchanges is to reduce the transrnission of HIV among drug injecting
clients. However, the HIV infection rate among drug injectors III
Multnomah County was estimateq by Ithe Oregon State Health
Division to be approximately 4%. ThiiS low infection rate, in
combination with a relatively low number of research subjects, made
it impossible to detect a change i,n the rate of infection.
Outside In did track changes in the rate of Hepatitis B among
subjects as a possible indicator of shar,ing of syringes. Hepatitis B IS
spread in a similar manner as HIV, and exposure to Hepatitis B
indicates that the client is also at risk i for HIV. Results are reported
later in this paper.
7. Do needle exchange programs irncrease the likelihood of drug
injection among non-injecting drug users?
The major criticism of nee~i1e exchange programs IS that they
promote and condone drug use. The concern is that either people not
using drugs will begin using, or ~hat people using drugs but not
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injecting will begin to inject because of the easy availability of free
syringes at an exchange.
Outside In decided to test this hypothesis by comparing two
groups of high-risk youth, one with easy access to an exchange and
one without access.
The first group was older homeless youth (ages 18-20) using
Outside In's Drop In Center, which is in a building right next door to
the Needle Exchange Program. The second group was youth using
Whitebird Clinic in Eugene, Oregon, a city located one hundred miles
from Portland, and one which does not have a needle exchange
program. Whitebird Clinic is a social service agency similar to Outside
In. The intent was to interview youth at both agencies at three
month intervals and assess whether youth in Portland began
injecting at higher rates than youth in Eugene. All youth were paid
$5 per interview.
The study was discontinued for two reasons: first, because
Whitebird Clinic did not fulfill the conditions of the contract and
conduct follow-up interviews, and second, because subject groups
were not comparable. Whitebird Clinic conducted 96 interviews
from 6/30/90 to 8/31/90. Interviews were discontinued for two
months due to staffing problems. They were resumed for one month
beginning November 1, 1990, and then discontinued permanently.
In September 1990, Eugene subjects were compared to
Portland subjects (using chi square), and serious comparability
problems discovered (Table I). Portland subjects were younger than
Eugene subjects: over half (62%) of Portland subjects were aged 18 to
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20, while less than one-fourth (22%) of Eugene subjects were this
age.
Subjects also differed in education, employment, student I status
and homelessness. Seventy two percent of Portland sJ.lbjects lacked a
high school diploma, while only 26% of Eugene subject~ did. Over
half (54%) of Eugene subjects had some college or were college I
graduates, while only 13% of Portland subjects did. In Eugene, 12%
of subjects were students, while only 2% of Portland subjects were
students. In Portland 67% of subjects were unemploYetd, and 61)%
lived in shelters or on the streets, In Eugene, 34% of subjects \vere
unemployed, and only 17% lived in shelters or on the streets. I
TABLE I
COMPARISON OF NON-INJECTING DRUG USERS IN PORTLAND (N=165)
WITH NON-INJECTING DRUG USERS IN EUGENE (N=86) I
Portia nd Eugene p<
Age .000
<18 1% 5%
18-20 62% 22%
21-25 24% 39%
26-30 4% 12%
31-40 4% 19%
>40 5% 3%
Sex .834
Male 73% 27%
Female 72% 28%
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TABLE I
COMPARISON OF NON-INJECTING DRUG USERS IN PORTLAND (N=165)
WITH NON-INJECTING DRUG USERS IN EUGENE (N=86)
(continued)
Portland Eugene p<
Education .000
< 9th Grade 9% 1%
9-11 Grade 63% 25%
High School Graduate 15% 20%
Some College 12% 39%
College Graduate 1% 15%
Employment .000
FuIl-Time 8% 11%
Part- Time 10% 15%
Occasional 12% 19%
Unemployed 67% 34%
Disabled 1% 7%
Homemaker 0 2%
Student 2% 12%
Residence .000
Own Place 13% 34%
With Someone Else 21% 33%
Boarding House 3% 2%
Shelter 42% 0
Street 18% 17%
Other 3% 14%
Differences between groups in all these categories were
statistically significant. Because subject groups were so different,
and because Whitebird Clinic was unable to continue participating In
the study, this component of the study was discontinued.
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DESCRIPTION OF CLIENTS PARTICIPATING IN THE STUDY
During the two-year study period, 1,145 drug injectors used
the Exchange. Demographic information on 710 clients enrolled in
the research component is reported in Table II.
Clients were predominately male (86%) versus female (14%).
The average age was 34, ranging from age 18 (the youngest legally
allowed to use the Exchange) to age 72. Only 6% of clients were ages
18 through 20, indicating that the Exchange did not attract many
young users -- despite the fact that Outside In is primarily a youth-
serving agency, and is located one block from a public high school.
Clients were primarily white (79%). Of the remaining 21%, 9%
were Native American, 8% African-American, 3% Hispanic, and 1%
Asian/Pacific Islander.
Forty-nine percent of drug injectors in the study had not
finished high school, and 19% obtained a high school diploma only.
While only 3% were college graduates, an additional 29% had
attended college.
Nearly half (45%) of clients were unemployed, with an
additional 13% disabled. Of the 40% who reported working, only 9%
were employed full-time. Ten percent were employed part-time,
and 21% reported occasional employment only.
Forty percent of respondents reported their job as their major
source of income, 22% reported illegal or possible illegal activities as
their major source of income, and 22% reported welfare or disability.
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The remainder (16%), received most of their income from their
partner, family, friends, unemployment benefjts, or other sources.
Although 77% of clients considered themselves to have a
religious affiliation, 41% stated that their reli~ious beliHs did not
influence how they lived. Forty-six percent said their beliefs
influenced how they lived somewhat strongly, and 13% said beliefs
influenced their life very strongly.
Many clients were homeless or "street people" -- 143% living
either in shelters or on the streets. Of the others, 22% Ihad their own
place, 16% lived in someone else's place, and 9% lived iin a boarding
house. Most (86%) had been in jail or prison.
TABLE II
DESCRIPTION OF 710 DRUG INJECrORS USING
THE NEEDLE EXCHANGE PROGRAM
Age (mean 34; range 18-72):
18-20
21- 25
26- 30
31-35
36-40
41-45
46-50
51+
Sex
Male
Female
6%
11%
18%
20%
22%
14%
6%
3%
86%
14%
TABLE II
DESCRIPTION OF 710 DRUG INJECTORS USING
THE NEEDLE EXCHANGE PROGRAM
(continued)
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Ethnicity
White
Native American
African Am~rican
Hispanic American I
Asian/Pacific Islander
Highest Grade Completed
1- 8
9-11
High School Graduate
Some Colleg~
College Graduate
Current Work Status
Full-Time Work
Part-Time Work
Occasional Work
Unemployed
Disabled
Other
Major Source of Income :
Job
Unemployment Benefits
Disability B~nefits
Welfare
Spou s e/P a rt~ler
Other Family Members
Friends
Illegal/Possible Illegal I Means
Other
79%
9%
8%
3%
1%
6%
43%
19%
29%
3%
9%
10%
21%
45%
13%
2%
40%
2%
9%
13%
3%
2%
2%
22%
7%
TABLE II
DESCRIPTION OF 710 DRUG INJECTORS USING
TIffi NEEDLE EXCHANGE PROGRAM
(continu~d)
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Religious Affiliation
None
Protestant
Catholic
Muslim
Easter
Jewish
Other
How Strongly Religious Beliefs
Influence Hqw They Live
Not at All
Somewhat Stlrongly
Very Strongly
Where Respondent Lives
Own PlaQe
Someone EIsel's Place
Boarding House
Shelter
On the Streets
Other I
Has Client Ever Been in Jail or
Prison I
No
Yes
23%
40%
24%
1%
3%
1%
8%
41%
46%
13%
22%
16%
9%
20%
23%
10%
86%
14%
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TABLE II
DESCRIPTION OF 710 DRUG INJECTORS USING
TIlE NEEDLE EXCHANGE PROGRAM
(continued)
How Client Heard about the
Exchange
Partner or Friend
Acquaintance
Referral from Another Agency
Media/Publicity
Reason Client Came to the
Exchange
Money
HIV Test
Syringes
Worried About AIDS
Curious
Other
Source of Syringes
Drugstore
Another IDU
Buys on the Street
Grocery Store
Relative
Other
60%
22%
8%
10%
29%
19%
18%
8%
7%
19%
52%
18%
13%
6%
4%
7%
As reported in Table III, most clients began drinking alcohol at
an early age. Some clients were born with alcohol in their system
due to their mother's alcohol use during pregnancy. Twenty percent
of clients first became intoxicated before age nine, 50% at ages ten
through fourteen, 26% at ages 15 through 19, and 4% over age
twenty. Twenty-two percent of clients were drinking daily or almost
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daily before age 15, with an additional 47% beginning to drink daily
between ages fifteen and twenty. Only three clients (less than 1%)
reported never using alcohol.
Most respondents (62%) began USIng illegal drugs before age
20: 18% began using before age 16, and 44% began using between
ages 16 and 20.
Other than alcohol, marijuana was the drug most frequently
tried at some time by clients, with 98% reporting using it. Ninety-
one percent of clients currently used alcohol and 84% used
manJuana. Clients frequently used drugs other than the drugs they
were injecting: 55% used cocaine, 43% used amphetamines, and 38%
used heroin, all without injecting.
Of those injecting drugs, 96% of clients had injected heroin at
some time in their life, 95% had injected cocaine, and 84% had
injected amphetamines. These three were the most frequently
injected drugs, although by no means the only ones. One client even
reported injecting alcohol -- not because he thought he got
intoxicated more quickly, but simply because he enjoyed shooting up.
Clients were usually not in drug treatment programs (86%).
Approximately one-third of clients had tried Alcoholics Anonymous,
and one-third Narcotics Anonymous.
Over one-fourth (28%) of respondents reported they had not
had sex in the past six months. Of the 72% who did, 39% had a single
partner, and 61% had multiple partners. Of clients with only one
partner, 82% never used condoms. Of clients with multiple partners,
50% never used condoms. Sixty percent of clients reported having a
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sex partner who also injected drugs. Twenty-three percent of clients
traded sex for money in the past six months, and 22% traded sex for
drugs.
When asked how likely they thought they were to develop
AIDS, 13% of clients stated they had no chance of doing so. Sixty-
eight percent thought they had some chance of infection, 15% a high
chance, and 4% a sure chance.
A concern raised about needle exchange programs is that they
might attract people to inject drugs who otherwise would not have
done so. From the surveys administered clients, it is clear that by far
the majority of clients had long histories of IV drug use. Of those
surveyed, 98% had been injecting drugs for at least one year, and
over 75% had been injecting five or more years.
TABLE III
ALCOHOL/DRUG USE, SEXUAL PRACTICES AND PERCEIVED HIV RISK
OF 710 CLIENTS OF THE EXCHANGE
Age First Intoxicated
Less Than Age 5
Age 5-9
Age 10-14
Age 15-19
Age 20-24
Age 25+
2%
18%
50%
26%
3%
1%
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TABLE III
ALCOHOL/DRUG USE, SEXUAL PRACTICES AND PERCEIVED my RISK
OF 710 CLIENTS OF THE EXCHANGE
(continued)
Age First Drinking Daily or Almost Daily
Less Than Age 5 0
Age 5-9 3%
Age 10-14 19%
Age 15-19 47%
Age 20-24 17%
Age 25+ 14%
Age First Used Illegal Drugs
Age 5-10
Age 11-15
Age 16-20
Age 21-25
Age 26-30
Age 31+
History of Drug Use
Alcohol
Paint Thinner
Marijuana
Crack
Cocaine
Amphetamines
Heroin
Heroin & Cocaine Mixed
Other Opiates
Barbiturates
Tranquilizers
PCP
MDA
Ni tra tes/Poppers
Other Drugs
No
.4%
70%
2%
41%
6%
12%
18%
36%
44%
47%
47%
61%
18%
64%
88%
1%
17%
44%
17%
11%
10%
Yes
99.6%
30%
98%
59%
94%
88%
82%
64%
56%
53%
53%
39%
82%
36%
12%
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TABLE III
ALCOHOL/DRUG USE, SEXUAL PRACTICES AND PERCEIVED mv RISK
OF 710 CLIENTS OF THE EXCHANGE
(continued)
Frequency of Non-Injecting Drug Use (Past Six Months)
Alcohol Marijuana Cocaine Amphet-
amines
Never 9% 16% 45% 57%
< 4 times. month 19% 33% 37% 29%
Once/week 15% 13% 7% 5%
2-6 times/week 24% 16% 7% 5%
Once/day 9% 7% 1% 2%
2-3 times/day 10% 8% 2% 1%
> 4 times/day 14% 7% 1% 1%
Heroin Heroin &
Cocaine
Never 62% 52%
< 4 times.month 28% 40%
Once/week 1% 2%
2-6 times/week 3% 4%
Once/day 2% 2%
2-3 times/day 3% 0
> 4 times/day 1% ()
History of Injecting Drug Use No Yes
Cocaine 5% 95%
Amphetamines 16% 84%
Heroin 4% 96%
Heroin & Cocaine 3% 97%
Non-prescription Methadone 69% 31%
Other Opiates 44% 56%
Barbiturates 55% 45%
Tranquilizers 81% 19%
PCP 79% 21%
MDA 76% 24%
N itra tes/Poppers 98% 2%
Other 65% 35%
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TABLE III
ALCOHOL/DRUG USE, SEXUAL PRACTICES AND PERCEIVED HIV RISK
OF 710 CLIENTS OF THE EXCHANGE
(continued)
Frequency of Drug Cocaine Ampheta- Heroin Heroin &
Injection (Past Six mInes Cocaine
Months)
Never 13% 32% 12% 20%
< 4 times.month 39% 32% 29% 44%
Once/week 14% 10% 12% 15%
2-6 times/week 20% 14% 14% 12%
Once/day 4% 3% 9% 2%
2-3 times/day 4% 5% 14% 3%
> 4 times/day 6% 4% 10% 4%
Non-Pres Other Barbit- Tranquil-
Methadn Opiates ua tes Izers
Never 65% 53% 81% 72%
< 4 times.month 23% 31% 15% 24%
Once/week 6% 5% 1% 1%
2-6 times/week 4% 5% 2% 0
Once/day () 1% 0 3%
2-3 times/day 0 3% 1% 0
> 4 times/day 2% 2% 0 0
PCP MDA Nitrates Other
\Poppers Drugs
Never 84% 81% 50% 57%
< 4 times.month ]6% 11% 33% 21%
Once/week 0 6% 17% 0
2-6 times/week 0 0 0 15%
Once/day 0 2% 0 0
2-3 times/day 0 0 0 7%
> 4 times/day 0 0 0 0
CurrentIy_ Enrolled in Drug Treatment
No 86%
Yes 14%
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TABLE III
ALCOHOL/DRUG USE, SEXUAL PRACTICES AND PERCEIVED HIV RISK
OF 710 CLIENTS OF THE EXCHANGE
(continued)
Weeks of Drug Treatment (Past Six Months)
None 63%
1- 4 20%
5-10 7%
11-26 10%
History of Attendance In Self-Help
Alcoholics Anonymous
Narcotics Anonymous
Cocaine Anonymous
Sexually Active (Past Six Months)
No
Yes
Groups
No
67%
68%
94%
28%
72%
Yes
33%
32%
6%
Number of Sexual
1
2
3
4
5
6-10
>10
Partners If Sexually Active (Past Six Months)
39%
16%
12%
6%
5%
11%
11%
Sexual Partner Injected Drugs (Past Six Months)
No 40%
Yes 60%
Had Sex For Money (Past Six Months)
No
Yes
77%
23%
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TABLE III
ALCOHOL/DRUG USE, SEXUAL PRACTICES AND PERCEIVED HIV RISK
OF 710 CLIENTS OF THE EXCHANGE
(conti nued)
Had Sex For Drugs (Past Six Months)
No
Yes
Frequency of Condom Use -- Single Partner
Never
Less Than Half the Time
Half the Time
More Than Half the Time
Always
78%
22%
(Past Six
82%
6%
2%
3%
7%
Months)
Frequency of Condom Use -- Multiple Partners
Never
Less Than Half the Time
Half the Time
More Than Half the Time
Always
(Past Six
50%
20%
8%
11%
11%
Months)
History of Blood Donations (Since 1985)
No 51%
Yes 49%
History of Blood Transfusion
No 81%
Yes 19%
How Likely Client Thought They
No Chance
Some Chance
High Chance
Sure Chance
Were to Develop AIDS
13%
68%
15%
4%
87
RESEARCH RESUlTS
Research Question 1: Will Drug Injectors Use A. Needle Exchange
Program In A State Where Syringes Are Legally Available Over-The-
Counter?
Introduction. Syringes are legally available in Oregon, sold in
pharmacies and sometimes in small markets (usually in areas
frequented by drug injectors). The only exception to this is that
syringes may not be sold to minors unless it is I for an authorized use
and by order of a physician. However, thle fact: that syringes are
legally available to adults does not always mean they were readily
available. Drug injectors told us they welre sometimes hassled when
they went to purchase syringes.
When Outside In proposed a Needle Exchange Program, there
was some question whether drug injectors would use it. The Oregon
State Health Division had conducted a survey of 161 drug injectors in
Multnomah County from December 1988 to Ma1rch 1989. Seventy-
eight percent of those surveyed reported obtaining syringes
primarily from pharmacies or stores. Based on this study, many
people concluded that drug injectors would not luse an exchange in
the state of Oregon.
There were other factors that were anticipated to limit the
number of drug injectors using the Exchange located at Outside In.
First, Outside In is not located in an area which is heavily frequented
by drug injectors, so that drug injectors would have to go out of their
way to exchange their syringes. Second, Cutside In did little
advertising to attract clients. Third, Outsi e In I issued a maximum of
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ten syringes per visit, making it inconvenient for frequent injectors
and those living at a distance to use the Exchange. Finally, Outside In I
could not give syringes to minors due to a law prohibiting this,
thereby excluding a large number of potential clients who were
street youth using other agency programs.
Whether drug injectors would use the program was an
important question to answer. Syringes are legally available in
thirty-eight states, and illegal in only ten. It may be that syringe
exchange programs are needed in only ten states, not fifty.
Resu Its. During the first two years of operation, 1,145
unduplicated drug injectors used the Needle Exchange Program.
These clients made a total of 6,369 visits to the Exchange. The
Exchange had an average of 265 visits per month, or about twelve
visits per day.
During the first year of operation, 18,784 syringes were issu~~d
and 16,418 returned, for a syringe return rate of 87%. The syringe
return rate improved each year (with a slight dip during the fourth
year). During the second year, 29,969 syringes were issued, and
28,790 returned, for a return rate of 96%. By the fifth year of
operation, the Needle Exchange Program was issuing over 100,000
syringes annually, with a syringe return rate of over 100%.
Over the five years the Exchange has been in operation, clients
have made 21,468 visits to the Exchange. Despite the legal
availability of syringes, the inconvenient location of the Exchange,
and the other limitations listed above, drug injectors did use the
program.
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TABLE IV
VISITS TO THE NEEDLE EXCHANGE PROGRAM: AND SYRINGES ISSUED
AND RETURNED, FIRST FIVE YEARS OF OPERAnON
New Client Syringes Syringes Syringe
Clients Visits Issued Returned Return
Rate
1st Year 773 3,291 18,784 16,418 87%
2nd Year 372 3,087 29,969 28,'1790 96%
3rd Year 3,199 72,355 73,448 102%
4th Year 6,216 84,249 83,812 99%
5th Year 5,675 107,141 109, ',753 102%
Totals 21,468 312,498 312,221 100%
(Note: New clients were tracked for the two-year study period only).
Over the two-year study period, the Exchange slaw an average
of 48 new drug injectors per month. There were two~ time periods
which were exceptions to this: In the third i;1nd fourth month after
the Exchange opened (January and February 1990), 1~38 and 117
clients respectively used the Exchange. This 'Was a result of paying
subject fees in the amount of $11, which attracted clients who were
more interested in the money than in actually using the Exchange.
In mid-February, subject fees were reduced tq $5, which had an
immediate effect on the number of clients using the program.
In the last two months of the study (S~ptemberI and October
1991), the number of new clients declined to 17 per month. This can
most likely be attributed indirectly to the Exchange's I funding
problems in early September. This was widely reported in the media
along with statements that the Exchange woulp be closing. Although
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the Exchange was never closed, drug injectors were understandably
confused about its status.
Research Question 2: Will Drug Injectors Using A Needle Exchange
Program Decrease Risky Needle Use Behavior Over Time?
Introduction. There was some question whether drug injectors
would change risky needle use behavior to try to protect themselves
from HIV, even if the means for affecting change was made readily
available to them. Would they go out of their way to try to protect
themselves from one disease -- HIV, while at the same time exposing
themselves to other health problems through continued IV drug use?
In addition, because of the fact that they are often high, it was
thought that they would be less likely to consistently and rationally
remember to use safe needle practices.
Results. Data collected at intake were compared with data
collected at six months and then at twelve months to assess change
in risky needle use behaviors. All data collection was done during
the first two years the Exchange was in operation, as the research
component was funded for these two years only.
Clients were those who joined the study and had completed
both the intake and follow-up surveys. There were 109 clients who
fit these criteria. Clients joining the study were a subset of clients
using the Exchange. During the first two years of operation, 1,145
drug injectors used the program, although not all of these clients
joined the study. Demographics, drug use, and sexual practices of
710 drug injectors who joined the study are reported in Tables II
and III above. These study participants differed from non-
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participants only in I that they were more: frequent users of the
Exchange (p<.OOl). Of those clients who: jpined the study, 109 came
in at both the intakle and six-month datal Gollectioni points.
A repeated measures MANOVA in!di~ated that clients
significantly decreased risky needle use Ibf(haviors lover the six
month study period. I Change was signifioaQt (P.$..05 !) on the following
variables: dru!? injection frequency, bOTjrowing us~~d syringes,
sharing rinse water, i using sterile sY~'inges, lending syringes to sex
partners, using new syringes, and cleaning used syringes with bleach
before reusing. Change on these v(lTiable~ was consistently towards
less risky behavior, and on no vari~ble re~arding l'isky needle use
was there stati~itica1'ly significant chilngel towards more risky
behavior (Table V).
TABLE V
COMPARIS()N OIF CHANGE IN RISK BEHAVIORS OF 109 NEEDLE
EXCMANGE CLIENTS AT INTAKE AND SIX MONTHS
Intake 6-month Trial
Variable n Mean Mean Effect p
Present IV Freq (x'/month) 109 131.8 I 22.2 .024
Did not share works 108 I .58 I .64 .367
Reused clean worksl 77 .50 .61 .157
Rented works 107 .10 .06 .418
Borrowed wor~s 108 .20 .10 .028
Shared cooker 108 .38 .28 .328
Shared nnse water 108 .34 .24 .035
Used sterile syringe 108 .57 .66 .033
Used sterile wqrks/no reuse 108 .28 .33 .304
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TABLE V
COMPARISON OF CHANGE IN RISK BEHAVIORS OF 109 NEEDLE
EXCHANGE CLIENTS AT INTAKE AND SIX MONTHS
(conti nued)
Variable
Lent used
n
works to:
running partner 106
sex partner 106
friend or other 1 06
Intake
Mean
.21
.19
.18
6-month
Mean
.18
.12
.12
Trial
Effect p
.525
.022
.069
Discarded used works 105
Sold dirty works 106
Reused own dirty works 106
Reused own cleaned works 106
Used new works 104
When used clean syringe
used:
bleach 58
alcohol 59
boiling in water 5 9
rinse in water only 59
.53
.09
.22
.57
.60
.39
.12
.07
.55
.44
.07
.13
.50
.70
.58
.07
.02
.36
.568
.213
.123
.055
.007
.002
.057
.009
.003
These analyses were extended through MANOVA analyses of
behavior change among clients who came in at intake and the
twelve-month data collection point (n = 74; TABLE VI). Similar
analyses were conducted for clients who came in at all three
timepoints of intake, six months and twelve months (n = 48; TABLE
VII).
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TABLE VI
COMPARISON OF 74 DRUG INJECTORS AT INTAKE AND 12 MONTHS
Variable
Present IV Freq (x/month)
Did not share works
Reused clean works
Rented works
Borrowed works
Shared cooker
N
73
74
60
74
74
74
Intake
Mean
38.0
.57
.56
.10
.18
.37
12-mo
Mean
18.8
.60
.65
.06
.11
.28
Trial
Effect p
/000
,570
,115
,241
,022
,064
Shared rinse water 74
Used sterile syringe 74
Used sterile works/no reuse 74
Lent used works to:
running partner 74
sex partner 74
friend or other 74
Discarded used works 74
Sold dirty works 74
Sold/gave cleaned works 74
Reused own dirty works 74
Reused own cleaned works 74
Used new works 73
When used clean syringe
used:
bleach 45
alcohol 45
boiling in water 45
rinse in water only 45
.38
.54
.25
.20
.22
.15
.56
.01
.10
.18
.58
.59
.42
.08
.05
.52
.23
.73
.4
.15
.15
.10
.43
.02
.10
.14
.53
.65
.65
.05
.03
.37
,004
,000
,001
,172
,103
,080
,030
,397
1,000
\344
\318
\095
.. 000
..490
.. 554
.018
(Note: IV frequency is measured in times injected per month; the
variables are measured in proportion of time the behavior occurs
when injecting)
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The change towards safer needle use behaviors observed at the
six-month point continued for clients who came in twelve months
later. Most variables that showed significant change at six months
continued to be significant at twelve months. In addition, "using a
sterile syringe once and never reusing it" was not significant at six
months but reached significance at twelve months. This was true for
both clients who came in at intake and twelve months only, and for
clients who came in every six months.
TABLE VII
COMPARISON OF 48 DRUG INJECTORS AT INTAKE, 6 MONTHS
AND 12 MONTHS (T2 IS DIFFERENCE BETWEEN INTAKE
AND 6 MONTHS, T3 IS DIFFERENCE BETWEEN
INTAKE/6 MONTHS AND 12 MONTHS)
Intake 6-mo 12-mo T2 T3 Trial
Variable N Mean Mean Mean p p Effect p
Present IV Freq 48 33.13 27.63 17.69 .413 .004 .032
(x/month)
Did not share works 48 0.61 0.66 .65 .498 .845 .779
Reused clean works 35 .51 .63 .59 .336 .051 .213
Rented works 48 .10 .07 .04 .336 .051 .115
Borrowed works 48 .19 .09 .09 .031 .083 .017
Shared cooker 48 .35 .33 .24 .734 .049 .163
Shared rinse water 48 .34 .32 .18 .808 .001 .014
Used sterile syringe 48 .55 .64 .77 .107 .002 .002
Used sterile 48 .24 .30 .43. .306 .002 .003
works/no reuse
TABLE VII
COMPARISON OF 48 DRUG INJECTORS AT INTAKE, 6 MONTHS
AND 12 MONTHS (T2 IS DIFFERENCE BETWEEN INTAKE
AND 6 MONTHS, T3 IS DIFFERENCE BETWEEN
INTAKE AND 6 MONTHS AND 12 MONTHS)
(continued)
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Intake 6-mo 12-mo T2 T3 Trial
Variable N Mean Mean Mean p p Effect p
Lent used works to:
running partner 48 .22 .15 .12 .119 .140 .098
sex partner 48 .23 .16 .12 .125 .051 .047
friend or other 48 .18 .10 .09 .018 .032 .005
Discarded used 48 .56 .37 .36 .008 .118 .010
works
Sold dirty works 48 .02 .02 .00 1.00 .290 .454
Sold/gave cleaned 48 .10 .07 .09 .290 .793 .549
works
Reused own dirty 48 .17 .14 .14 .554 .699 .740
works
Reused own cleaned 48 .60 .57 .52 .605 .219 .361
works
Used new works 48 .62 .67 .67 .168 .598 .388
When used clean
syringe used:
bleach 27 .40 .59 .61 .006 .051 .003
alcohol 27 .06 .07 .02 .787 .054 .180
boiling in water 27 .05 .03 .03 .425 .425 .522
rinse in water only 27 .55 .36 .37 .022 .089 .011
Research Ouestion 3: Will Frequent Users Of A Needle Exchange
Program Change Risk Behaviors More Or Less Than Infrequent Users
Of An Exchange?
Introduction. This part of the study compared frequent users
of the Exchange with infrequent users. It was hoped that regular use
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of the Exchange, and regular contact with program staff by clients
would have a beneficial effect on risky needle use behaviors. There
was also a question of some clients using the program somewhat
inappropriately: they came in at three-month intervals to
participate in the study and collect subject fees, but did not
otherwise make use of the Exchange.
Clients were separated into those who used the Exchange less
than four times in six months, and those who used it four or more
times. Clients coming in less than four times were almost certainly
coming for interviews only, as there were three interview points in
that time period (intake, three-month and six-month interviews).
Results. Two significant differences were found between
frequent and infrequent users of the Exchange. The frequent
attendees reported significantly greater risk reduction on "borrowing
syringes" and on "using syringes and then throwing them away."
This latter result indicates that frequent users of the Exchange were
using the program as intended, that is, returning syringes for safe
disposal rather than simply discarding them.
The analyses also shows that while all clients reduced
frequency of drug injection over time, frequent attendees reduced
injection frequency less than infrequent attendees. While this did
not reach significance (p<.09), it is worthy of note. Further analysis IS
needed to determine whether this is a methodological artifact
analogous to regression to the mean (since those who increase their
injection frequency will be more likely to need new syringes more
often); a result of personal characteristics of these subjects (such as
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the stage of their addiction); or is an unintended effect of the
program (Table VIII).
Table VIII
RISK BEHAVIOR AMONG CLIENTS WHO USED THE EXCHANGE LESS
THAN FOUR TIMES (N=34) AND CLIENTS WHO USED
THE EXCHANGE FOUR OR MORE TIMES (N=83)
AT SIX-MONTH FOLLOW-UP.
No. of Intake Six Group Trial Group/
Visits Mean Month Trial
Mean
Shooting Up <4 28.7 8.9 .022 .039 .099
Now >4 33.0 30.7
Did Not Share <4 .58 .60 .660 .164 .380
Syringes >4 .56 .66
Cleaned <4 .50 .52 .284 .177 .343
Syringes >4 .53 .66
Rented Used <4 .14 .14 .004 .260 .260
Syringes >4 .08 .03
Borrowed Used <4 .19 .19 .109 .021 .021
Syringes >4 .20 .07
Shared Cooker <4 .33 .29 .484 .050 .322
/CoUon >4 .40 .29
Shared Rinse <4 .30 .22 .272 .017 .778
Water >4 .37 .26
Got Syringe In <4 .56 .66 .756 .044 .724
Sterile >4 .59 .66
Wrapper
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Table VIII
RISK BEHAVIOR AMONG CLIENTS WHO USED THE EXCHANGE LESS
THAN FOUR TIMES (N=34) AND CLIENTS WHO USED
THE EXCHANGE FOUR OR MORE TIMES (N=83)
AT SIX-MONTH FOLLOW-UP.
(continued)
No. of Intake Six Group Trial Group/
Visits Mean Month Trial
Mean
Got Syringe In <4 .33 .35 .350 .315 .635
Sterile >4 .26 .32
Wrapper.
Used Once &
Threw Away
Used - Gave to <4 .23 .22 .391 .397 .724
Running >4 .21 .17
Partner
Used - Gave to <4 .23 .14 .590 .020 .694
Sex Partner >4 .19 .12
Used - Gave to <4 .20 .18 .146 .051 .360
Friends >4 .18 .11
Used - Threw <4 .50 .57 .214 .363 .026
Away >4 .54 .38
Used - Sold <4 .01 .02 .805 .665 .126
Without >4 .02 .01
Cleaning
Reused After <4 .09 .05 .454 .117 .692
Cleaning >4 .10 .08
Reused <4 .19 .17 .978 .108 .228
Without >4 .23 .12
Cleaning
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Table VIII I
RISK BEHAVIOR AMONG CLIENTS WHO USED THE EXCHANGE LESS
THAN FOUR TIMES (N=34) AND CLIENTS WHO USED
THE EXCHANGE FOl)R OR MORE TIMES (N=83)
AT SIX-MONTH FOLLOW-UP.
(continued) ,
No. of Intak¢ Six Group Trial Group/
Visits Mean Month Trial
Mean
Cleaned With <4 .24 .43 .005 .001 .939
Bleach >4 .45 .64
Cleaned With <4 .17 1.0 .103 .058 .631
Alcohol >4 .09 .05
Cleaned by <4 1.0 .03 .321 .009 .312
Boiling >4 .05 .02
Cleaned With <4 .64 .46 .182 .003 .940
Water >4 .53 .35
Research Question 4: Will Drug Injectors Using A Needle Exchange
Program Change Risk Behaviors More Or Less Than A Comparison
Group Of Drug Injectors Not Using A Needle Exchange Program?
Introduction. Ideally, a r~search study should consist of a
group of subjects who are given a treatment, and a similar but
separate group of subjects who ~lre not gIven the treatment. Subjects
would be randomly assigned to ~roups, and the two groups would be
compared to determine whether ~he treatm(~nt had an effect. A
common criticism of studies of ~leedle excbange programs is that
they do not include comparison groups.
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Many AIDS prevention measures appear to achieve some
success with targeted :clients. Needle exchange programs ideally
should be evaluat~d not only in terms of whether change in client
behavior improvec\, but whether it improved more than change
affected by other AIDS prevention programs.
This study was Glesigned to include a comparison group of drug
injectors not using the Needle Exchange Program. The study
evaluates whether neeOle exchange programs are better or worse
than another apprqach 'to AIDS prevention. It compared drug
injectors using the Exchange with drug injectors not using the
Exchange, but rec~iving a range of interventions from an outreach
project. The comparison group was drawn from the county's NIDA-
funded outreach project to IV drug users. A limitation of the
evaluation is that there was not random assignment of drug injectors
to the two progra~ns. I
Results. Clients, for the companson group were drawn from the
Portland NADR outreach project. This was not an ideal comparison
group in that drug injectors in the NADR project did receive
interventions. As a result, this is not a comparison of drug injectors
using a needle ex~~hange program with drug injectors receiving no
intervention, but a comparison of two different HIV education and
intervention programs. All NADR clients received bleach and were
provided with HIV edUication. A subset either participated in groups
or received one-on-one, counseling. They were also encouraged to
buy and use sterile syringes (legally available over-the-counter in
Oregon).
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Seventy-seven Exchange clients who attended the Exchange
four or more times were compared to 355 NADR clients.
Demographic information for both groups is shown in Table IX.
The comparison between these projects is complicated by
potentially different subject populations. While there were no
differences between the two samples on most demographic and drug
use variables, there were some differences observed. For example,
NADR subjects were considerably more likely to be female and
African American, and less likely to be male, and White or Native
American. NADR subjects were also more likely to live with someone
else and less likely to live on the streets. Perhaps because we were
studying frequent attenders of the Needle Exchange Program,
Exchange users at six month follow-up injected more frequently than
the NADR subjects. These differences between samples may limit the
conclusions that can be drawn from the comparison.
TABLE IX
COMPARISON OF SYRINGE EXCHANGE AND P-NADR RESPONDENTS
ON SELECfED VARIABLES AT INTAKE
Variable Syringe P(Chi-
Exchange P-NADR square)
Gender .0001
Female 14% 24%
Race .0001
Black 8% 27%
Hispanic 3% 3%
White 79% 65%
Native American 9% 4%
Asian/Pacific Islander 0.7% 0.2%
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TABLE IX
COMPARlSON OF SYRINGE EXCHANGE AND P-NADR RESPONDENTS
ON SELECTED VARIABLES AT INTAKE
(continued)
Variable
Age
18
19-25
26-30
31-40
41-50
51-77
Income from job in last 6 months
Yes
No
Income from family member
other than spouse
Yes
No
Income from a friend
Yes
No
Current work status
Working
Unemployed
Retired/Disa bled
Homema ker IS tudent
Current Living Situation
Own Place
Live at Someone Else's
Boarding House
Shelter
On Street
Other
Ever Used Crack Cocaine
Yes
No
Syringe
Exchange
1%
15%
18%
42%
19%
3%
59%
41%
18%
82%
25%
75%
40%
45%
13%
2%
22%
16%
9%
19%
23%
10%
59%
41%
P(Chi-
P-NADR square)
.25
1%
12%
15%
48%
21%
3%
.65
57%
43%
.006
25%
75%
.07
29%
71%
.04
35%
52%
11%
3%
.0001
24%
30%
12%
17%
11%
7%
.0008
68%
32%
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TABLE IX
COMPARISON OF SYRINGE EXCHANGE AND P-NADR RESPONDENTS
ON SELECTED VARIABLES AT INTAKE
(continued)
Variable Syringe P(Chi-
Exchange P-NADR square)
Ever Used Heroin and Cocaine .006
Together
Yes 64% 68%
No 36% 32%
Ever Used Opiates Other than .006
Heroin
Yes 56% 64%
No 44% 36%
Ever Used Tranquilizers .002
Yes 53% 62%
No 47% 38%
Use of Non-IV Cocaine .06
Yes 76% 81%
No 24% 19%
Use of Non-IV Amphetamines .03
Yes 80% 85%
No 20% 15%
Use of Non-IV Heroin .0002
Yes 31% 43%
No 69% 57%
Ever Injected Cocaine by Itself .32
Yes 95% 96%
No 5% 4%
Ever Injected Heroin by Itself .03
Yes 96% 99%
No 4% 1%
Ever Injected Cocaine and Heroin .74
Together
Yes 97% 97%
No 3% 3%
Ever Injected Amphetamines .98
Yes 84% 84%
No 16% 16%
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TABLE IX
COMPARISON OF SYRINGE EXCHANGE AND P-NADR RESPONDENTS
ON SELECTED VARIABLES AT INTAKE
(continued)
Variable
IV Use of Opiates Other than
Heroin
Yes
No
"Current" Drug Injection
Frequency at Intake
Zero
< 1 per Month
About Once per Week
2-6 Times per Week
About Once per Day
2-3 Times per Day
4+ Times per Day
Presently Enrolled in Drug
Treatment
Yes
No
Had Sex with Someone in Last Six
Months
Yes
No
Female Subject who had Sex with
Females in Last Six Months
Yes
No
Male Subject who had Sex with
Males in Last Six Months
Yes
No
Syringe
Exchange
55%
45%
3%
20%
16%
29%
9%
15%
8%
14%
86%
72%
28%
7%
93%
3%
97%
P-NADR
64%
36%
11%
23%
13%
21%
9%
17%
6%
0%
100%
85%
15%
7%
93%
3%
97%
P(Chi-
square)
.02
.0001
.0001
.0001
.95
.99
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TABLE IX
COMPARISON OF SYRINGE EXCHANGE AND P-NADR RESPONDENTS
ON SELECTED VARIABLES AT INTAKE
(continued)
SELECTED OTHER VARIABLES ON WHICH THE lWO SAMPLES W,ERE
NOT SIGNIFICANTLY DIFFERENT
Highest School Grade Completed
Completed GED Certification
Source of Income Unemployment Benefits
Source of Income Disability Payments
Source of Income Welfare
Source of Income Alimony
Income from a Sex Partner
Illegal Source of Income
Illegal Drug First Used
Number of Years Since They Started to Inject Drugs
Ever Used Alcohol, Glue/Paint, Cannabis, Cocaine by Itself,
Amphetamines, Heroin by Itself, Non prescription Methad~me,
Barbiturates, PCP, Nitrites/Poppers, or Combinations of Drijgs
not Mentioned
Non-IV Use of Heroin and Cocaine Mixed, Non-prescription
Methadone, Opiates Other than Heroin, Barbiturates,
Tranquilizers, PCP, Nitrites, or Combinations of Drugs not
Mentioned
Currently on Probation
Currently on Parole
Currently Facing Criminal Charges
Sex Partner an IDU
Needle Exchange subjects (n=77) were compared with Portland
NADR subjects (n=335) at intake and at six months. Subjects in both
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projects report significantly lower levels of risk over a wide range of
risk behaviors at follow-up than at intake. In fact, change was
significant and in a positive direction on 15 of the 22 variables
(Table X). One otber variable, reuse of clean works, showed a trend
towards pqsitive cqange.
TABLE X
MANOVA OF 77 NEEDLE EXCHANGE CLIENTS AND 335 PORTLAND
NADR CLIENTS AT INTAKE AND 6 MONTHS
Variable Program N Intake 6 Mo. Group Trial Group
Mean Mean Effect Effect by
p P Trial p
Current NEP 77 33.6 27.5 .004 .000 .057
Drug P-NADR 335 29.2 12.2
Injection Both 412 28.3 19.7
Frequency
Did Not NEP 77 .56 .65 .324 .231 .080
Share P-NADR 335 .59 .57
Works Both 412 .58 .58
Used Clean NEP I 56 .51 .65 .000 .008 .261
Works P-NADR 243 .69 .75
Both 299 .66 .73
Rented NEP 76 .09 .03 .569 .000 .280
Used P-NADR 333 .07 .04
Works Both 409 .07 .04
Borrowed NEP I 77 .20 .07 .038 .000 .122
Used P-NADlR 334 .21 .14
Works Both 411 .21 .12
Shared NEP 77 .40 .28 .110 .000 .834
Cooker P-NADlR 334 .44 .33
ICoUon Both 411 .43 .32
Shared NEP 77 .35 .26 .206 .000 .590
Rinse P-NADlR 334 .40 .28
Water Both 411 .39 .27
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TABLE X
MANOVA OF 77 NEEDLE EXCHANGE CLIENTS AND 335 PORTLAND
NADR CLIENTS AT INTAKE AND 6 MONTHS
(continued)
Variable Program N Intake 6 Mo. Group Trial Group
Mean Mean Effect Effect by
p P Trial p
Got Works NEP 77 .58 .66 .069 .002 .819
From P-NADR 335 .63.62 .72
Sterile Both 411 .71
Wrapper
Got Works NEP 77 .26 .32 .098 .040 .832
From P-NADR 334 .30 .38
Sterile Both 411 .29 .36
Wrapper,
Used Once
Used New NEP 77 .60 .70 .112 .000 .633
Works P-NADR 334 .58 .65
Both 411 .58 .66
Lent Used Works to:
Running NEP 77 .20 .17 .743 .097 .741
Partner P-NADR 334 .20 .16
Both 411 .20 .16
Sex NEP 77 .18 .12 .294 .011 .976
Partner P-NADR 333 .20 .15
Both 410 .20 .. 14
Friend NEP 77 .18 .10 .037 .000 .872
or Other P-NADR 335 .21 .15
Both 412 .20 .14
Discarded NEP 76 .54 .40 .810 .076 .002
Used P-NADR 335 .44 .48
Works Both 411 .46 .46
Sold or NEP 77 .10 .08 .699 .045 .580
Gave Away P-NADR 335 .10 .07
Cleaned Both 412 .10 .07
Works
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TABLE X
MANOVA OF 77 NEEDLE EXCHANGE CLIENTS AND 335 PORTLAND
NADR CLIENTS AT INTAKE AND 6 MONTHS
(conti nued)
Variable Program N Intake 6 Mo. Group Trial Group
Mean Mean Effect Effect by
p P Trial p
Reused NEP 77 .23 .12 .002 .000 .038
Syringes P-NADR 335 .13 .09
without Both 412 .15 .09
Cleaning
Reused NEP 77 .58 .52 .026 .055 .953
One's Own P-NADR 335 .51 .46
Clean Both 412 .52 .47
Works
When Cleaned Used Syringe, Proportion of Times Did With:
Bleach NEP 42 .44 .63 .017 .000 .830
P-NADR 200 .34 .52
Both 242 .36 .54
Alcohol NEP 43 .10 .05 .012 .043 .736
P-NADR 200 .18 .12
Both 243 .17 .10
Boiled NEP 43 .06 .02 .333 .060 .29;5
Syringe P-NADR 200 .03 .02
in Water Both 243 .04 .02
Rinsed NEP 43 .54 .34 .028 .000 .39.~
Works P-NADR 200 .59 .47
in Water Both 243 .58 .45
Only
On most of these measures, no statistically significant
differences in the amount of risk reduction were found between the
experimental and control groups. However, Syringe Exchange
subjects were significantly better on two variables involving risky
injection behavior: reduction in the extent to which subjects re-usec;l
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syringes without cleaning, and the extent to which they no longer
threw away used syringes (but returned them to the IExchange). This
latter finding is of importance in that while both projects increased
the likelihood thC1t clients would use a syringe one tLme only, the
Exchange led cli~nts to return syringes for $afe disposal. This
reduced the number of syringes discarded pn the streets and in other
public places, anI=! thel possibility of accideqtal needle I sticks to the
general public.
Clients of both Iprojects reduced drug injection :frequency at six
months. However, as noted above, clients qf the Needle Exchange
Program reduced freqmency of injection less; than did clients of the
NADR project. Whilel this did not reach significance (ip<.057), it does
indicate a trend, and Ifurther research is needed in this area.
Differences are lof particular significa\1ce in thalt syringes are
legally available in Oregon, and the bleach outreach! program
encouraged drug injectors to buy and use ;sterile syriinges.
Differences betwe;,en the Exchange and the NADR outreach program
are likely smalle~' than they would be between an ex:change and an
outreach program in at state where purchase;. of syringes was illegal.
Of considerable I importance is the fac( that the :Needle Exchange
Program and the bleach outreach project s~em to recruit different
clienteles. There was little overlap between the samples, with the
Portland NADR projec!t finding that only 11% of its sample had ever
used the Needle Exchange Program. Thus, it appears that syringe
exchanges and ol.Jtreaah programs might be~;t be seen. as
complementary s~rateg;ies that recruit and produce risk reduction
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among different sub-populations of drug injectors, rather tha~l as I
competing options that should be chosen among to find which is the
best approach to HIV prevention.
Research Question 5: Does A Needle Exchange Program Have An
Impact On The Community In Terms Of A Change In The Number Of
Discarded Syringes On The Streets? .
Introduction. The primary goal of needle exchange program~ IS
a reduction in the sharing of syringes and therefore in the
transmission of HIV among drug-injectors. However, it is po~~sible:
that exchanges could have a significant seconctary benefit for the I
general public by removing possibly contaminated litter from the'
streets.
A syringe exchange could have an effect on discarded ~;yringes
similar to the effect Oregon's "bottle bill" has on discarded pop CarlS
and bottles. Syringes would be less likely to be discarded because
they are now worth something. Used syringes could now be
exchanged for new, sterile syringes.
This sub-study was conducted to determine the effect of a I
needle exchange program on the number of discarded syringes in. the
vicinity of the Exchange. It was possible that the Exchange would I
decrease the number of syringes on the streets by leading injectors
to return syringes to the Exchange rather than discarding them in I
public places. It was also possible that the Exchange would qraw I
drug injectors into the neighborhood and increase the number of I
discarded syringes in the area.
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Results. In the three and one-half months prior to the start of
the Exchange, 18 syringes were found, or 5.14 per month. During the
twenty months following the start of the program, 38 syringes were
found, or 1.9 per month.
Table XI presents data comparing the number of days on which
syringes were and were not found prior to and subsequent to the
opening of the Exchange. Syringes were significantly more likely to
be found prior to its opening (chi-square = 4.048; p<.05).
In spite of the fact that syringe exchanges aim to increase the
availability of (sterile) syringes for drug injectors, this exchange has
not led to an increase in the number of discarded syringes with
which children or others might stick themselves. Instead, it reduced
the number of discarded -- and possible contaminated -- syringes in
the streets. This finding confirms reports (not based on quantitative
before/after data) that the problem of discarded syringes was eased
by exchanges in Tacoma (Holly Hagan, personal communication,
1992) and Amsterdam (Des Jarlais 1992b).
Outside In raised the issue of discarded syringes to obtain
funding for the Needle Exchange Program from the City of Portland.
Outside In is currently issuing over ] 00,000 syringes annually, and
the syringe exchange rate for the past year (11/93 - 11/94) has
been 102%. This means that drug injectors are actually returning
more syringes to the Exchange than they are given. Outside In
argued that preventing 100,000 syringes per year from being
discarded, possibly III public places is a significant public health
benefit. The City of Portland granted the Needle Exchange Program
112
$10,000 per year for 1993-94 and for 1994-95. Each year the grant
was made on a one-time-only basis.. Starting in fiscal year 1995-96,
the city agreed to add the $10,000 to its budget on an on-going basis.
A rationale for the award was that it did indeed fulfill a public safety
function by keeping discarded syringes out of public places and out
of waterways.
The City of Portland's Dffpartment of Environmental Services
produced a "Syringe Control Stl/dy"l report in April 1992 that
included a recommendation to ~upport and expand needle exchange
programs simply on the basis that they help prevent syringes from
ending up in waterways.
The city wanted to deternline why syringes were found in
Portland's waterways, primarily the I Willamette River and Columbia
Slough. The city did interviews, surveys and field inspections. For
25 days they monitored the nUJ11ber of syringes entering the
Columbia Boulevard sewage trffatment facility.
They concluded that less fhanl 2% of syringes were entering
waterways through the sanitary sew,er system. Almost 25% of
syringes were either discarded qn the banks of rivers or other
waterways, thrown directly into walterways, or discarded in the
streets and carried to rivers by storm water runoff.
The city Bureau of Environm1ental Services recommended that
first, drug injectors be educated to :properly dispose of syringes, and
second, that Outside In's Needle;. Exchange Program be supported and
expanded to help reduce syringe liltter.
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TABLE XI
NUMBER OF DAYS ON WHICH SYRINGES WERE AND VVERE NOT FOUND
PRIOR TO AND SUBSEQUENT TO THE OPENING OF THE EXCHANGE
No synnge
Syringe
Total Search Days
% of search days on which a syringe
was found
Before After
7/14/89 11/2/89 Totals
52 62 114
14 6 20
66 68 134
21.2% 8.8% 14.9%
Xl =4.05, p<.05
Research Question 6: Are There Differences In The Rate Of Spread Of
HIV Infection Among Users And Non-Users Of The Needle Exchange
Program?
Introduction. The goal of needle exchange programs is to
prevent sharing of drug injection equipment in order to prevent
accidental sharing of blood between drug injectors, and therefore the
transmission of HIV. The ultimate measure, therefore, of whether
needle exchange programs are successful, is the extent to which they
affect the HIV seroprevelence rate among drug injecting clients.
Resu Its. As discussed earlier, it was impossible to detect
differences in the rate of spread of HIV infection among clients due
to the small number of clients and the low rate of seroprevelence
(4%) among the drug-injecting population.
The HIV infection rate among 169 clients at intake was 3.9%.
There was only one HIV seroconversion at the four data collection
points during the twelve months of data collection. This single
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seroconversion was noted at the three month follow-up point, so it is
quite possible that this person may have become infected prior to
beginning to use the Exchange (TABLE XII).
TABLE XII
HIV SERaCONVERSIONS IN THE EXCHANGE RESPONDENTS
AT EACH FOLLOW-UP POINT
Follow-up Point
Total N
HIV- to HIV+
HIV+ to HIV-
3-mo
169
<1%
0%
6-mo
139
0%
0%
9-mo
63
0%
0%
12-mo
77
0%
0%
The infection rate for hepatitis B core antibody at intake was
much higher -- 52% of the 169 clients tested at intake. The risk for
seroconversion to Hepatitis B increased with each three-month
interval. A Wilcoxon, signed-ranks test was used to compare
seroconversion rates. Three clients seroconverted at 3 months, 12 at
six months, 21 at nine months, and 22 at twelve months. The rate of
seroconversion was not significant at intake (p=.18), was showing a
trend at three months (p=.06), and was significant at both six months
(p<.03) and twelve months (p<.04) (Table XIII).
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TABLE XIII
HEPATITIS B SEROCONVERSIONS IN THE EXCHANGE RESPONDENTS
AT EACH FOLLO\V-UP POINT
Follow-up Point
Total N
Hep- to Hep+
Hep+ to Hep-
3-mo
169
.3
o
6-mo
1139
12
1
9-mo
63
21
o
12-mo
77
22
3
This could indicate that drug injectors using a needle exchange
program are not consistently practicing safe needle use behaviors.
Hepatitis B is transmitted by sharing of injection equipment in the
same way HIV is transmitted.
However, there are limitations to I this interpretation. First,
there is no comparison group and no way to know whether there
would be a greater or fewer number of seroconversions among a
group of drug injectors not ul,iing a needle exchange program.
A second limitation of (he data is. that different groups of drug
injectors were present at each of the fom data collection points. Only
22 clients were tested at all four of th,e three-month intervals. These
22 clients were likely the more regular: users of the Exchange.
Seroconversion data for these 22 clients is more encouraging. No
clients seroconverted at three months, one at six months, two at nine
months, and two at twelve months. None of these changes is
significant (Table XIV). How~ver, the small number of clients (22) is
a limitation on drawing conclusions.
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TABLE XIV
SEROCONVERSION FOR HEPATITIS B FOR CLIENTS
PRESENT AT ALL FOLLOW-UP POINTS
Follow-up Point
Total N
Hep- to Hep+
Wilcoxin P
3-mo 6-mo 9-mo 12-,no
22 22 22 22
o 1 2 2
1.00 .32 .18 .18
There is evidence that drug injecting clients of the Exchange
obtained syringes from safer sources over time (Table XV). Although
most c1ient~ were initially obtaining syringes from safe sources and
did not change over I time, at three months 79% of 175 clients
reported using a safe source, 38% using the Exchange, and 21% using
a store or pharmacy. Ten percent obtained syringes on the stre~~t, 9%
from anoth~r drug imjector, and 2% found them or obtained them
from other ;sources. I At six months, 87% of 127 clients reported using
a safe source, 60% using the Exchange, and 27% using a store or
pharmacy. The remaiining 13% obtained them from a spouse or
partner, a qealer or other sources.
TABLE XV
CHANGE IN SAFETY OF SOURCE OF SYRINGES OF EXCHANGE
CLIENTS AT 3 AND 6 MONTHS
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N Less NNo
Follow-up N Safe N Safer Change Z p
3 month 175 1 .. 26 129 2.15 .030_. l.
6 month 127 7 29 86 3.20 .001
DISCUSSION AND RECOMMENDATIONS
SUMMARY
Most cases of AIDS among th~ heterosexual population in this
country are linked to IV drug use. The ideal method for curbing the
epidemic among drug injectors is drug treatment and non-use of
drugs. Because of unavailability of treatment: slots, unreadiness of
drug injectors for entry into treatment and the high probability of
relapse, treatment cannot be relied on as the answer to the epidemic.
Education is an essential pre-requisite for changing risky
behaviors, but again is not the answer in and ,of itself. Drug injectors
must not only be aware of the dang~r of AIL,IS and knowledgeable
about how to protect themselves, bu~ they must have the means to
protect themselves.
Use of bleach to disinfect syringes is considered a "second-
rank" intervention. Bleach may not be as effective as once thought in
sterilizing syringes, particularly if dnlg injectolrs do not follow all the
recommended steps to clean them. Needle exchange programs make
sterile syringes available to drug inj~ctors as I the most direct means
of helping this group reduce sharing of syringes and therefore the
transmission of HIV.
The evaluation of the Needle Exchange Program at Outside In in
Portland, Oregon helped answer questions about these programs, and
showed that such programs can be beneficial in a number of ways.
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The project demonstrated that drug injectors will use needle
exchange programs to try to protect themselves from AIDS, even in a
stalte where syringes are legally available to them. During the first
fOlUT years of the Exchange, nearly 2,000 drug injectors made
approximately 16,000 visits, despite the fact that the Exchange is not
located in an area frequented by drug injectors.
Clients of the Exchange reduced risky needle use behavior from
intake to six months. There was no change to less safe practices on
any risky needle use variable. Change lasted over time: at twelve
months after intake, change in behaviors that were significant at six
months continued to be significant.
The study compared frequent users of the Exchange (visiting
the Exchange four or more times in six months) with infrequent
users (less than four times in six months). Frequent users differed
on two variables: they borrowed syringes less than infrequent users,
and were less likely to use a syringe and throw it away (but rather
returned it to the Exchange). There was a trend (although it did not
reach significance) for frequent users to reduce injection frequency
less than infrequent users, and this merits further study.
Drug injectors using the Exchange were compared to drug
in}ectors not using the Exchange, but participating in a county-
sponsored HIV outreach, education and bleach distribution project.
Clients of both projects significantly reduced risky needle-use
behaviors, with Exchange clients significantly better on two
variables: re-using syringes without cleaning, and throwing away
used syringes. Clients of the Exchange reduced frequency of injection
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less than did non-clients, although this did not reach significance.
The two projects attracted different groups of drug injectors, and
should be viewed as complementary rather than competing AIDS
prevention strategies.
The effect of the Needle Exchange Program on the community
was evaluated in terms of the change in the number of discarded
syringes found on the streets in the vicinity of the Exchange. A
search for syringes was begun three and one-half months prior to
the opening of the Exchange, and was continued for twenty months
after the Exchange opened. The number of syringes found per month
decreased from 5.14 before the Exchange opened to 1.9 after it
began. Decreasing the possibility of accidental needle-sticks by the
general public is a significant side benefit of a needle exchange
program.
CONCLUSIONS
The data presented here support the growIng body of evidence
that Needle Exchange Programs produce behavioral risk reduction.
They also provide evidence that the number of potentially infected
syringes in public places can be reduced by opening syringe
exchanges.
Comparisons between Exchange clients and NADR clients are
preliminary, with further analyses needed. A limitation of the data IS
the possible difference between the two samples discussed earlier.
The two projects also differed in that the Exchange did not collect
locator information on clients, and the NADR project did. A smaller
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percent of clients of the Exchange returned for follow-up interviews
(and of course could not be contacted and reminded). A additional
uncertainty is the usual limitation of self-reported data.
Syringe exchange and bleach outreach programs are best seen
as strategies that complement each other. They recruit different
populations of drug injectors, and both lead to risk reduction.
Differences between programs are probably smaller than in a
city where syringes are illegal and the bleach outreach programs
could not encourage people to buy sterile syringes.
One of the most significant aspects of this study is that there
was a comparison group of drug injectors not using the Needle
Exchange Program. Almost all evaluations of needle exchange
programs have assessed change in behavior over time only of the
group of clients using the program. This has been a major criticism
of studies of these programs. Limitations of the comparison group
were potential differences between groups, and lack of random
assignment to groups.
During the first year of operation of the Exchange (1990/1991),
the program cost $112,000. That same year, the county outreach
project cost approximately $1,000,000. The Exchange employed
1.275 full-time equivalent (FTE) staff, while the county employed
6FTE outreach workers, 1.8FTE community health nurses, 0.2FTE
physicians, 1FTE health educator and IFTE program development
specialist. Altogether, the county employed 23.4FTE. They provided
services to 6,000 clients, including more than 200 drug injectors
participating in their extensive education and counseling groups.
12:2
Outside In provided services to approximately 1,300 clients. This
cost comparison is provided because given that funding for HIV
prevention programs is limited, the cost-effectiveness of various
programs should be a consideration when designing a community
response to the disease.
However. the county estimates' include costs of conducting
interviews (by outreach workers), while most interviews condu~:ted
at the Needle Exchange Program were done by volunteers -- an
impressive in-kind contribution. In addition, there are obvious
efficiences gained by a program operating at a fixed site and
attracting clients to come in (the Exchange), versus a program
employing outreach workers to go and find drug injectors (the
county NADR Project). Finally, it is usually the case that a small non-
profit agency is able to operate projects at less cost than can a lqrge:
government agency, and a needle exchange program operated by the
county would likely cost much more than did the one operated by I
Outside In.
The data presented in this study are, of course, not definitjve
evidence that syringe exchanges reduce the spread of HIV or oOler I
pathogens. Indeed, it is not likely that a truly definitive study can
ever be conducted of syringe exchanges, any more than this is
feasible with evaluations of drug abuse treatment or laws again~it
drug use. The cumulative weight of the research, however, and the:
fact that no studies have found any indication that the exchange!; al'e
doing any damage, clearly puts the burden of proof on opponent~ of
syringe exchanges. In the interim, given the dangers from HIV,
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syringes exchanges should beqome an important part of the Ipublic
health response to AIDS.
RECOMMENDATIONS
Non-Research Related Recommendatiollis
1. Drug treatment programs shlould be expanded and made
accessible. Treatment should be free and available on
demand.
2. Drug paraphernaliel laws that prevent needle distribution
should be repealed. Syringes should b~ available not
only through needle exchange programs, but oVler-the-
counter at pharma.,::ies. Syringe vending machintts should
be available so the,t drug injectors have access to sterile
syringes "after-hollrs," when programs and pharmacies
are normally c1oserd.
3. Needle exchange programs s:hould be t(\rgeted to: specific
groups and 10cate~1 in areas frequented by different sub-
groups of drug injectors
4. Needle exchange programs should explore ways of
reaching sex partn~rs of drulg injecting clients.
5. The federal government should revise laws that currently
prohibit use of fe~leral funds for needle: exchange
programs. Goverr,ments should suppor~, encourage and
fund needle exchange programs, and sllould fund
additional evaluations of these programs.
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Research Related Recommendations
1. Studies should be conducted with differf/,nt sub-groups of
drug injectors to assess the extent to which current
evaluation results can be generalized.
2. Needle exchange programs have less of an effect on
changing risky sexual behaviors than they do on changing
risky needle use behaviors. Research shCluld focusl on
how these programs can help reduce ris~y sex behaviors.
3. Amsterdam reported that needle exchan~e progralms
sometimes led to a greater number of dfscarded syringes
in public places, although overall, it is bvlieved that
large-scale expansion of needle exchange resulted in
fewer discarded syringes. Australia also reported: a
problem at one of there exchange sites with increased
numbers of discarded syringes (although the probllem
was corrected). This was not the experience of the
Portland Needle Exchange Program, nor t.hat of programs
in Tacoma, New York, San Francisco or Scinta Cruz :(Lurie
1994). However, Portland is the only city to conduct a
study both prior to and after the opening of an eXiChange.
Communities considering opening such programs should
consider a pre-post evaluation of discard~d syringt'ts on
the streets.
4. Although it is clear that drug injectors are changing their
behavior in response to the AIDS epidemi~, it is less clear
that they will be able to maintain changes in beha,vior
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over long pe~'iods of time. Research should be done to
gIve information aboUit what willi assist drug injectors in
maintaining long-term behavior change.
5. Evaluations should be done to determine which aspects of
program operations are most helpful or are barriers (i.e.
enforcement of a strict Ol1e-·to-one exchange of syringes,
hours of operation, fj,(ed sites v:ersus mobile units,
location of sites, limits on the number of syringes issued
per visit, an~j services provided other than needle
exchange).
6. Although random assignment to I groups may never be
possible, additional studies !~hou]d be done with
comparison groups of drug lnjecllors not using a needle
exchange pro,gram. To date'l Portland's study is the only
one that inch,Jded a comparis;on group. (New York's
evaluation included a i comp(~rison group, but used
baseline data collected from drug injectors from a time
period prior fO the opening of the legal exchanges.)
7. Clients of Pqrtland's Needle Exclhange Program reduced
frequency of injection I less ~)Ver Itime than a comparison
group of dru~ injectors not jJsing the Exchange --
although this differenae did not i reach significance.
Frequent attenders of I the E:xchange also reduced
frequency of injection less thanl infrequent attenders
although again this did not reach significance.
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Exchanges in Amsterdam, Wi'ales and Tacoma report that
clients of their program~ reduced injection frequency
(Lurie 1994). Programs in New York, San Francisco and
London reported mixed or neutral results. Further study
is needl~d in this area.
8. Although drug injectors -have reduced risky needle use
behavior in response to the A.IDS epidemic, they have not
eliminated risky behaviors. I Additional research is
needed to clarify risk hctors, determine reasons change
in behavior has and has not I occurred, and examine
differences between groups (e.g.. gender, race, age,
patterns of drug use, an(j sOlcial context).
9. Further investigation should Ibe conducted of the relation
of theories of behavior change and needle exchange
programs
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APPENDIX A
SELECfED CLIENT INTERVIEWS
Client interviews were conducted to give color to the variety of
individual experiences, and to put a human face on the data
summarized in the statistical tables. Following are brief summaries
of the lives of eighteen drug-injecting clients in order of the date on
which they were interviewed. They were interviewed by the Project
Director.
November 7, 1989
A thirty-one year-old white man has been living on the streets
for the past three months. He has graduated from high school, and
has had some college courses. He has two children, ages three and
five, but they are not with him, and he mainly lives alone. He
obtains his money primarily through illegal activities.
He first drank at age thirteen, and was drinking daily by age
sixteen. He started using pot at age sixteen, and first shot up at age
twenty-five. His drug of choice is cocaine, although he also uses
alcohol, pot, amphetamines, LSD and crack.
He cleans his syringes after using less than half the time. He
shares syringes with his partner and with friends. He's aware of the
danger of AIDS, and in fact when he was recently in New York, he
tried (unsuccessfully) to find the New York Needle Exchange
137
Program, calling both the health department and the mayor's office.
He had a HIV test five months ago, but never went back for the
results.
He has been to detox once recently. He has spent three weeks
In jail in the past six months, and is currently facing criminal charges.
He is bi-sexual. Of the twelve partners he's had in the last six
months, half were female and half male. Almost all his partners
were also dmg injectors, and he sometimes trades sex for money. He
never uses a condom because he doesn't like them and he feels safe
enough.
November 20, 1989
A forty-six year-old white man lives alone in his own
apartment. He never graduated from college, but did get his GED. He
has one child, age 17, who does not live with him. He gets money
both from working and from involvement in illegal activities.
He never drank or used drugs until age twenty-five. He now
drinks and uses both heroin and cocaine. He always cleans his
syringes, but in water only. He shares all injection equipment --
syringes, cookers, cotton and rinse water -- with both friends and
strangers.
He's been In detox once and in jail once. In the past six months
he's had two sex partners, both female and both also drug injectors.
He never uses condoms because he doesn't like them.
138
November 27,1989
A fifty-eight year-old white man has been living alone in his
own apartment for five months. He is disabled, and gets money from
the Veteran's Administration and from Social Security. He's been in
jail two and one-half years out of the past five years. He has no
sexual partner (and has not had- sex in the past six months), and has
no children.
He started drinking at age nme, and was drinking daily by age
twenty-one. He first shot up at age 17, and currently uses cocaine,
heroin and alcohol.
He always cleans his synnges, but usually with water only.
He's more interested in getting high than m always being safe. He
obtains syringes at a store or buys them on the street. He shares all
injection equipment (syringes, cookers, cotton and water) with
others, including strangers.
He has been in detox four times, residential treatment two
times, a prison treatment program once, methadone programs three
times, and in out-patient treatment twice. His health is fair. Drugs
are the most important thing is his life.
November 28, 1989
A forty year-old Native American woman lives alone in her
own apartment. She is a high school graduate and has had some
college. She has a seventeen year-old child who does not live with
her. She is unable to work full-time, and gets money from her
spouse, jobs and food stamps.
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She first drank when she was thirteen years old, was drinking
daily a year lat~r, and first injected drugs at age thirty-eight. She
primarily shoots cocaine. She shares syringes and injection
equipment with her I sex partner. She cleans her syringes either with
peroxide, alcohol or water.
She has been in residenti<ll treatment programs six times, and
used to attend Alcoholics Anonymous meetings. Recently, she spent
a week in jail, and lis currently facing criminal charges.
She has hild three sex partners in the last six months, all male,
three of whom were also drug injectors. She sometimes trades sex
for drugs. She nev,'er uses condoms, partly because her partners
don't like them, ancl partly because she doesn't think about them
when she's ston~d. I She's never had an AIDS test because she's too
embarrassed.
December 2. 1989
A forty-two yi~ar-olcl white woman lives in a cave on a hill
that's under a sfreetl here in Portland. She has graduated from high
school. She is unemployed, and obtains money from jobs and food
stamps. She has one seventeen-year old child who is not living with
her.
She first startl~d drinking at age fourteen, and first shot drugs
at age eighteen. Sqe currently uses alcohol, and shoots cocaine,
heroin and amphetamines.
She share~~ syringes and injection equipment with sex partners
and with friends. She uses syringes she knows have been used. She
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cleans them, but usually with water only. She doesn't use bleach to
clean syringes because she's afraid of it.
She has been in detox three times, and In a residential program
once. She hasn't been in jail recently, but is currently facing criminal
charges.
She has had one sex partner in the past six months. He is also a
drug injector. They never use condoms. She has had her tubes tied,
and he doesn't like condoms. She has had both pneumonia and
hepatitis in the past six months. She hasn't had an HIV test because
her veins are so bad. They're so bad that she sometimes had to "skin
it when fixing."
December 20, 1989
A thirty-five year-old white woman has not graduated from
high school. She has a job, and lives with her spouse. She has three
children, ages seven, nine and seventeen. They don't live with her --
she put them all up for adoption.
She first started drinking at age eighteen, and was drinking
daily by age nineteen. She started injecting drugs a year later. She
shoots heroin, opiates and narcotics. She uses used syringes about
half the time, and shares with her sex partner and with her running
partner. She never cleans syringes before using as it isn't practical --
she shoots up on the streets.
She's been with one partner for four years now, a man who is
also a drug injector. They never use condoms because she's had her
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tubes tied. She's never had an AIDS test. Her partner was tested,
but he never returned for the results.
December 22, 1989
A forty year-old white man was an army kid and was born in
Germany. He's disabled, and lives in a hotel by himself. He has one
child, age twelve, who does not live with him. He never graduated
from high school. He gets his money from welfare and from food
stamps.
He first used alcohol at age thirteen, and was drinking daily by
age seventeen. He first shot up at age nineteen, and shoots
amphetamines, cocaine, heroin and barbiturates.
He gets syringes either on the streets or from a man he knows
who's a diabetic. He shares syringes with others, including strangers.
He cleans his syringes either with water or with after-shave lotion.
He's been in a residential treatment program once. He's been
in jail before, and is currently facing criminal charges.
He hasn't had sex in the past six months. He says he's never
had a HIV test because he's not a homosexual.
December 28, 1989
A forty-eight year-old white man has lived on the streets now
for thirteen years. He lives alone. He has one child, age seventeen,
who does not live with him. He has been to college. He is currently
unemployed, and obtains money primarily through illegal activities,
although he also receives food stamps.
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He started drinking at age fifteen, and first shot drugs at age
twenty-five. He shoots cocaine, heroin and amphetamines. He
shares syringes and injection equipment with his sex partner,
running partner and with friends. He borrows used syringes, and
gives away his after he uses them. He never cleans his syringes:
he's either too high, too sick, or it takes too much time.
He has been in detox about forty times, in residential treatment
programs six times, and in outpatient treatment once. He walked out
of the Harmony House treatment program just this morning. He has
been in jail before, and is currently facing criminal charges.
He was a pimp from age twenty-one to age twenty-seven. He's
had sex with four women in the past six months. He [,ever uses
condoms -- he doesn't think about them when he's high. He's never
hadl an AIDS test because he doesn't think he's at risk for AIDS.
Delcember 28, 1989
A forty-six year-old white man lives alone in a hotel room. He
has no children and is unemployed. His parents recently died, and
he gets $300 per month for the next fifteen years from an
inheritance. He also gets food stamps and obtains money from illegal
activities.
He first started drinking at age sixteen, and was drinking daily
by age thirty. He shoots heroin, cocaine, opiates, narcotics, and
amphetamines. He shares syringes and injection equipment with his
running partner and with strangers. He both rents and borrows used
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syringes. He always cleans his syringes, but usually in water only.
Anything else takes too much time, and he just wants to get high.
He has been in detox once, in a residential treatment once, and
in outpatient treatment once. He was in Rocky Butte jail once for
thirty days seventeen years ago.
He hasn't had sex in the past six months. His health is poor. He
hasn't had an AIDS test because he believes he has a high chance of
having AIDS, and is afraid of getting a positive test result.
December 29, 1989
A thirty-six year-old white man has spent ten years on the
streets, and currently lives in a shelter for the homeless. He never
finished the eighth grade. He is a fisherman who has worked only
one day in the past six months. He has a sex partner and no children.
He obtains money from his family, sex partner and from friends.
He started using alcohol at age twelve, and was drinking daily
by age thirteen. He shoots amphetamines, opiates and cocaIne. He
also uses alcohol, pot, crack, LSD and sniffs glue and paint thinner.
He rarely shares syringes. However, he has only purchased
them once, and gets them either from drug dealers or finds them on
the streets. He just came to Portland from San Francisco, where
syringes cost $2 to $4 each, depending on whether they are new, and
on how badly you need them. He does give his syringes to others
when he's finished, and he does share cookers, cotton and rmse
water. In the past, he cleaned his syringes with water or hydrogen
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peroxide. Now, he always uses bleach (although last night he used
water only).
He has been ~n one treatment program when In jail (years ago).
He goes twice a day to Alcoholics Anonymous, and is also in Narcotics
Anonymous.
He is bi-sexu(1.l, and has had an estimated one thousand sex
partners in the last six months, approximately four hundred women
and six hundred men. He has traded sex for drugs.
He is HIV po~itive, and had two positive tests, one nine months
ago and one five mqnths ago:. He uses condoms most of the time,
because he doesn't want to give his partners AIDS, but he doesn't
always remember to do so if Ihe's high. So far his health is good.
January 8, 1990
A thirty-four African-American man is disabled and lives on
the streets. He Iive~ alone and has no children. He is a high school
graduate, and gets ~ little money from family and friends.
He started drinking alcohol at age five, and was drinking daily
at age nineteen. H~~ first shot up at age twenty-eight, and shoots
cocaine and heroin. He also uses alcohol and crack. He shoots up
either at parties or pn the streets. He shares syringes and injection
equipment with partners, friends and strangers. He uses a new
syringe about half tpe time,and he gets his syringes by asking
around. He doesn't clean his, syringes very often -- it takes too much
time, and he's more interested in just getting high.
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He has be~n in I detox ten times. He hasn't has sex in the past
six months. He hasn't had a HIV test because he doesn't like needles.
January 9, 1990.
A twenty-~;evenl year-old white man has less than an eighth
grade education and bas been liying on the streets for five months.
He is unemploYf!d, and mainly gets money through illegal means. He
also receives food stamps. He came to the Exchange for two rea~;ons:
first, he's broke and Iwants the subject fee, and second, he's beerl
shooting dope fqr twelve years and thought he should. get checked
out.
He first drank alcohol at age five, and shot up speed at ag~
thirteen. He sh90ts cocaine, heroin and amphetamines. He also uses
alcohol, pot, LSD and! opiates. He shares syringes and injection
equipment with whoever he is shooting with. He never cleans
syringes because he's: usually too high and it would take too much
time.
He has been in detox three times, and in pnson treatment
programs three ~imes: He occasionally attends Narcotics Anonymous
meetings. He's I)een in jail six weeks out of the last six months.
He has ha~ tenl sex partners in the past six months. All were
women, and all put one were also drug injectors. He has sex for
money and sex for dlrugs. He never uses a condom, partly beca4se he
doesn't like therp, and partly because he doesn't think about it when
high.
He IS HIV positive. His health IS fair. He had hepatitis re~:ently.
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January 10, 1990
A forty year-old white man lives with a friend in an
apartment. He attended college for awhile. He no longer has a fuIl-
time job, but does occasional work.
He first started drinking ~t age thirteen, first used drugs at age
fifteen, and first shot up at age nineteen. He shoots heroin, which is
his "drug of choice." He doesn't share syringes: "I may be a heroin
addict, but I'm conservative in my traits. Sharing gives addicts a bad
name." He does share cookers and cotton.
He has been in detox four times, in residential treatment four
times, in methadone programs six times, and in out-patient
treatment twice. He hasn't been in jail for at least five years.
He has had three sex partners in the past six months, all
women, two of whom were also drug injectors. He has never used a
condom in his life. He doesn't like them.
He is very knowledgeable about AIDS, and has read extensively
on the subject: "if potentially affected by anything, I read up on it."
He has not had an AIDS test because it's too inconvenient to get one.
January 18, 1990
A twenty-four year-old African-American man is a Muslim
who lives alone in a hotel. He has two children, ages four and ten,
who do not live with him. He is a high school graduate who had a
job, and now does occasional work.
He first drank and shot up at age sixteen. He shoots cocaine
only. He buys his syringes on the streets, and sometimes rents or
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borrows used syringes. He shares syringes with his sex partner. He
gives them when finished to his sex partner, running partner and
friends. He always cleans his syringes~ but with water only.
He has never been in a drug treatment program. He has been
in jail two years out of the past five. He is currently on probation.
He has had twenty sex partners in the past six months, all
women, half of whom were drug injectors. He has sex for money and
sex for drugs. He has never used a condom: "It's like wearing a
raincoat in the sun." He had three AIDS tests in the past six months,
and all were negative.
January 25, 1990
A twenty-four year-old white man considers himself to be
mentally disabled and is trying to get on Social Security disability.
He is homeless, and just goes to friend to friend for a place to stay.
He has not graduated from high school. He gets money from food
stamps, illegal activities, and his mom sent him fifty dollars.
He first drank at age fifteen, was drinking daily by age twenty-
one, and shot up at age twenty-four. He shoots cocaine only,
although he also uses alcohol, pot, glue and paint thinner, LSD,
poppers, nitrates, opiates and tranquilizers. He doesn't share
syringes, but does share other injection equipment. He gives his
syringes to his sex partner after he's used them, and always cleans
them with bleach except when he's lazy.
He has had one sex partner in the last SIX months, a woman and
a drug injector. He grew up as a Jehovah's Witness, and he's been in
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jail for four and one-half years and just got out last week (he's on
parole). Up until last week he was a virgin. Then he had sex with a
woman four times in one night. He used a condom because she didn't
want to get pregnant.
January 30, 1990
A forty-two Native American woman lives alone on the streets.
She is a high school graduate and has a six year-old child (who does
not live with her). Her major source of income is from illegal
activities.
She first used alcohol at age thirteen, was drinking daily by age
fifteen, and first shot up at age eighteen. She shoots cocaine and
heroin and uses alcohol. She buys her syringes on the streets. She
never uses a needle after someone, but does share cookers and
cotton. She cleans syringes half the time with bleach and half the
time with water.
She hasn't been in a drug treatment program for five years, and
has only spent two weeks in jail. She hasn't had sex for three years:
"when you do drugs, the urge is not there." She's never had an AIDS
test because she's afraid she'll find out she's infected.
February 1, 1990
A twenty-nine year-old white man has lived on the streets for
thirteen years. He has an eighth grade education, and gets money
from panhandling.
He first used alcohol at age sixteen, and was drinking daily by
age eighteen. He first shot up at age sixteen. He injects everything
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-- heroin, cocaine, amphetamines, opiates, PCP, and LSD. He even
injects wine and vodka, not because he thinks he']] get high faster,
but because he identifies himself as a "needle freak."
He shoots up at least four times a day. He shares with any and
everyone. Because he has tuberculosis, people make him use the
needle last. He shares s'yringes with his running partner, friends and
strangers.
He gets his needles from friends and on the streets. He used to
get them out of trash cans behind doctor's offices. In the past six
months, he used a new needle maybe twice. He doesn't clean them
because he's "lazy." If he finds a synnge on the ground, he's flush it
with water.
He's been In detox about two hundred and fifty times, in a
residential program twice, and in a methadone program once. He
was recently in jail for a year, is on parole, and is facing criminal
charges.
He hasn't had sex in the past six months -- it doesn't appeal to
him anymore because of the dope. He hasn't had an AIDS test, but is
sure he's infected. He's had hepatitis, tuberculosis and gonorrhea in
the past six months, lost thirty to forty pounds recently, can't sleep,
and has night sweats.
February 6, 1990
A twenty-one year-old Native American man is a high school
graduate and a Catholic. He has cancer (a tumor in his head). He's
been told for months that he's going to die in one month, so he
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doesn't go to the doctor anymore. He's staying with hisl girlfriend.
He has a three year-old child who doesn't live with him. His main
source of income is illegal activities, although he alsq gets money
from the Bureau of Indian Affairs (from selling his hmd:I).
He first drank at age eight, and was drinking clailYI by age
twelve. He first shot up -at age eight -- his cqusins l.ntmduced him to
shooting heroin. He shoots heroin, cocaine an~ opiat~s, ;and uses pot,
alcohol, crack, PCP and peyote.
He shares syringes and injection equipment wHh ihis running
partner, friends and acquaintances. He rents and bqrrows used
syrInges. He cleans syringes with a variety of methqds;, bleach,
alcohol, water, or boiling them in a pressure Gooker.
He has been in two prison treatment pro,grams. He has been in
prison for the past five years -- since age sixte;.en. He hlas been out
for one month.
He had sex with two men while in prison., and has I sex with
maybe forty-five women since he's been out (with ~~ixteen women
last week alone). He uses a condom about half the time.1 He doesn't
use one if he knows the partner.
He's pretty sure he has AIDS. If he test~ positive, Ihe plans to
go back to jail; he wants to be responsible ancl not if~feclt anyone else.
APPENDIX B
HISTORICAL OVERVIEW OF THE NEEDLE EXCHANGE PROGRAM
Overview
As my summary will indicate, the process of establishing a
needle exchange program began as a matter of direct problem-
solving by our social service agency, operating from a harm
reduction perspective. Over time this process grew to be another
matter altogether involving not only social service concerns, but
research concerns, inter-agency relationships, political
considerations, community and neighborhood problems, and legal
obstacles. I have summarized this engrossing process from my own
perspective as one of its central players. I have served as the
Executive Director of Outside In since1980.
Winter 1987. Two women tested seropositive for HIV in
Outside In's Prenatal Clinic. It was devastating for them and for
Outside In staff. One had an abortion. One moved out of state and
we never heard from her again. One was a former drug injector. One
had been a partner of a drug injector.
Giving away syringes seemed a logical response to the growing
HIV epidemic. I spoke with a local AIDS physician and researcher,
James Sampson M.D., who said that Amsterdam gave them away on
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an exchange basis. This made syringe distribution more palatable for
the Portland community.
As Executive Director of Outside In, I called around the United
States to find a needle exchange program so that I could model
Outside In's program after an existing one, but couldn't find one.
People in San Francisco said there weren't any, and referred me to
two researchers in New York, Don C. Des Jarlais Ph.D. and Samuel R.
Friedman Ph.D., who were interested in needle exchange.
When contacted, Drs. Des Jarlais and Friedman said this would
be the first needle exchange program in America, and would be
closely watched by other cities considering such programs. It was
therefore important to set it up as a research project, and they would
help find the research money for it.
Spring 1987. The concept of a needle exchange program was
presented to Outside In's Board of Directors. The Board approved the
program unanimously.
I attended the second International Conference on AIDS held in
Washington D.C., partly to meet with Drs. Des Jarlais and Friedman.
We talked to staff from the Centers for Disease Control. They
expressed interest in funding it as a research project. However, the
federal government soon issued their first ban (in 1987), on the use
of federal funds to support needle exchange programs.
Winter 1987. Don Des Jarlais and Sam Friedman wrote a
proposal to the American Foundation for AIDS Research (AmFAR) for
funding for needle exchange at Outside In. AmFAR agreed to fund
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the program (as a research project), and the program was scheduled
to open July 1, 1988.
June 1988. I flew to New York for a national press conference
set lIP by AmFAR, and flew back to New York several days later to
appE!ar on the Today Show. News of the opening of the Needle
Exchang,e Program was on the front page of the Oregonian, the
Washington Post, the Boston Globe, and the Los Angeles Times. The
phone calls and media attention were overwhelming.
June 1988. St. Paul Fire and Marine, Outside In's Insurance
company called to notify us that they were canceling our insurance.
I h~d notified Outside In's local insurance broker earlier that year
that we intended to start the exchange, and we asked if the agency
neec\ed additional insurance. She said no, as she thought it could be
cov~red as part of our clinic operations. The horne office in St. Paul
had not been notified, however. The home office uses a clipping
servjce, which notified them about the exchange because of the
natiqnal media coverage, and the home office decided to cancel our
Insurance.
The insurance commissioner of Oregon, Mr. Ted Kulingowski,
requested that St. Paul officials fly to Oregon and meet with him.
They did, but he was unsuccessful in changing their minds. Outside
In's attorneys held a telephone conference with St. Paul's attorneys,
but again were unsuccessful in changing their minds. St. Paul was
asked to simply continue coverage for the current Outside In
programs and allow the agency to obtain separate coverage for the
exchange elsewhere. They refused. If Outside In opened a needle
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exchang~ program, they wou~d cancel' insurance coverage for all
agency programs. Outside Ir,'s broker wrote St. Paul, suggesting that
a separate entity I be formed to run thle exchange which would rent
space in Outside lIn's building. This separate entity would not be
covered by St. Paul, but wO\lld obtain insurance elsewhere, would
carry a $1,000,000 policy; ant;! would name Outside In and St. Paul as
addition&l insuredL St. Paul wrote back that they would "cancel the
Outside In policies if a needle exchange program connected III any
way witn your 0lPeration is implement,ed." (letter of August 8, 1989).
Outside In delayed opening the progr;am.
JulY 1988., I began searching for other insurance companies.
The agency was ',limited to those few companies who provided
medical liability i:::overage for clinics. :
A company I was found that would insure Outside In, including
the needle exchange program, provided! we used a single use, non-
reusable syringe. I I became <I world-wide expert on single use
synnges, and tracked down at least ten prototypes of single use
syringes. The problem was that none were being mass produced
anywher~ in the :world, whicl,l made tbeir cost prohibitive ($2 per
syringe <;ompared to 10 cents for a relusable one).
Au,gust 1988. The best single u:se syringe seemed to be one
designed III England. The d~signers thought they had a manufacturer
lined up in Germany, and wQuld be in production in three months.
The deal fell through.
September ;1988. A single use synnge designed by Stephen
Glazier was found in New York. I contacted Glazier, who said he had
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the financing to produce and market the syring~s, and he would give
them free to the needle exchange program. H~ estimated that they
would be available before Christmas.
I planned to open the exchange January 1~ 1989. The deal for
free syringes fell through. I was told they would Clost forty to sixty
cents each. I ordered 5,000. They were never pr(])duced.
December 1988. I called Peter Evans at the World Health
Organization (WHO) in Geneva, Switzerland. WtIO Iwas funding
several countries to develop single use syringe~~ to: administer
vaccines in developing countries to prevent re-1,1se ,of syringes by
clinics and hospitals. He gave me several leads,
January 1989. Another single use syring~ was found in New
York, this one designed by Nick Sunday. He h~d a patent and was
trying to find a manufacturer.
I tried another approach: I called Becton Dickinson, the largest
manufacturer of syringes in the United States, ,llld iasked if they
would manufacture the English prototype. They said no, as they
didn't want to pay patent fees, and were developing a model of their
own. They asked if they could fly out and show their model to a
focus group of homeless youth drug injectors at Outside In.
They came to Outside In January 26th. T.he ffocus group gave it
mostly favorable reviews (e.g. "it's new, and I'd like to be the first on
my block to have oneil). While they were meeting;, other street youth
at the agency broke into the car being used by Becton Dickinson
representatives.and stole their luggage. Becton Dickinson never
manufactured the syringe.
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March 1989. Inject Syringe was the first single use syringe to
be tested by WHO, at Baxa Europe in Denm&rk. They told me they
could deliver up to 30,000 by April, and the cost would be $1 per
syringe. The deal fell through.
May 1989. It became clear that mass production of a single
use syringe was at least 'several years away I Furthelr, because these
syringes were not being designed for drug injectors, they were likely
to be problematic for our use. I contacted another insurance broker,
and searched again for an insurance company.
Outside In tried piecing together insur&nce packages. I found a
carrier to insure everything but the clinic (including the Needle
Exchange Program), and another to cover the staff physician and
nurses. However, there were potential gaps in covemge, so I
abandoned this possibility.
An insurance company was found who would insure Outside In,
including the needle exchange program, for $50,000 Ito $60,000
annually. The cost was prohibitive for my s~nall agency. We had
been paying $15,000 per year. The grani frqm AmFAR to pay for the
exchange and the research was only $50,000.
I gave up. I asked the County Health Departmtent to operate
the program. I wrote to the Board of County Commissioners,
reminding them that they were in charge of public llealth, requested
that they operate the program, and offered to give tbe health
department the $50,000 AmFAR grant. I b~lieved the program
ought to be implemented regardless of whetper Outside In could
operate it.
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The Board of County Commissioners wanted to see the program
implemented. The County Health Department did not want to
operate it themselves: (1) it would cost them far more than $50,000,
and (2) running the program with tax payer money would invite
more controversy than was desirable. They suggested that the Board
of County Commissioners· give Outside In $35,000 to pay for the
additional insurance costs.
I said no to the deal. It actually made a lot of sense to me for
the health department to operate the program, and I really had
given up. The Board of County Commissioners offered Outside In an
additional $15,000 to supplement the cost of the research. I said yes.
June 29, 1989. The MuItnomah County Board of Commissioners
approved $50,000 for Outside In's Needle Exchange Program.
$35,000 was for insurance costs, and $15,000 for research costs.
June 1989. An attorney, Mr. John DiLorenzo, attended the
Commissioners budget hearing on June 29, 1989. He owned the
Gentry Apartments, located one and a half blocks from Outside In on
southwest Salmon and Twelfth. He asked the county commissioners
to delay approving the money for the Needle Exchange Program on
the grounds that he had concerns that he wanted addressed first. His
concerns included a fear that the Exchange would attract drug
injectors to the neighborhood, and a concern that he did not know
whether Outside In was in compliance with Oregon's new infectious
waste disposal regulations. I assured the commissioners that Outside
In was in compliance with state regulations, and that I would be
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happy to meet with Mr. DiLorenzo about his c;oncerns. The
commissioners approved the funds.
July/August 1989. I met with Mr. Dil..orenzo and attempted to
address his concerns. He wrote me a letter August 18, 1989 saying
he wanted Outside In to enter into a contract with him personally.
We were unable to resolve our differences, howelVer, into a mutually
agreeable contract.
Example: I said Outside In would not ~jo a massive advertising
campaign or use billboards. Mr. DiLorenzo sajd we could do no
advertising of any kind.
Example: I offered to walk over and dispose of any syringes
Mr. DiLorenzo would find. He required that Qutside In be on call for
him twenty-four hours per day, seven days per week, and respond
within fifteen minutes during business hours and within one hour
after business hours.
Example: I offered to conduct a daily (Molflday through Friday)
syringe search in the immediate neighborhood. Nlr. DiLorenzo
wanted the search done of a four block area (wice per day (taking an
estimated three hours per day).
Mr. DiLorenzo repeatedly called the Hefllth I Department and the
county commissioners with concerns that Out~idel In wouldn't
contract with him, and that no one would be moruitoring the Needle
Exchange Program. He solicited Mr. Ron Spears, manager of a
building on twelfth and Salmon (owned by tb~ Schnitzers, a
prominent local family) to call tbe county and. say the Schnitzers
were concerned. He or Mr. Spears called Lincoln Higb Scbool (across
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the freeway from Outside In) and asked them to complain to the
county. The school refused.
Mr. DiLorenzo talked to Jacob Lewin at KINK radio and told him
he wasn't opposed to the Needle Exchange Program, but just wanted
Outside In to contract with him. KINK aired an editorial saying they
shared the concerns of Mr. DiLorenzo and asked the county to go
slowly and make more stipulations about the contract between
Outside In and MuItnomah County.
September 1989. The contract with MuItnomah County was
still delayed. The county said they would state in their contract with
Outside In that Outside In would negotiate with the neighbors in
good faith. I said that was fine. Mr. DiLorenzo said the statement
must read that Outside In and the neighbors must resolve issues to
their mutual satisfaction. I refused to agree to this.
October 5. 1989. Mr. DiLorenzo called the county's attorney.
He wanted to make sure Multnomah County was a co-insured of the
Needle Exchange Program, and implied clearly that he intended to
sue.
This tactic backfired. The county bailed out and decided to
have no involvement with, and do no monitoring of, the Needle
Exchange Program. They gave Outside In a contract for $35,000 for
Insurance and $15,000 to supplement the research and asked for a
final report. They told me they expected me to operate within the
law and good luck. Tbey told John DiLorenzo that if he had concerns
about monitoring of the program, he needed to address them with
AmFAR.
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Summer 1989. An insurance broker found an insurance
company, Clinic Mutual, which specialized in insuring clinics. They
offered reasonably priced liability insurance. They were a small
company in Tennessee. They said they would consider coverage for
Outside In, but then decided not to.
I called Dr. Merv Silverman, the Chair of the Board of AmFAR.
He called Clinic Mutual on our behalf. They said they're too small to
take a risk on an unknown program such as a needle exchange
program.
However, they sent a risk manager to Outside In September
first for a site review. He then recommended Outside In for
admittance. On September 19, Clinic Mutual accepted Outside In for
coverage.
October 17, 1989. The Board of Directors of Outside In
approved switching insurance companIes. Outside In canceled its
policy with St. Paul Fire and Marine. St. Paul wrote stating that "We
are disappointed that, in spite of even President Bush and HEW
Secretary Sullivan's statements questioning the validity of needle
exchange programs, the clinic is going ahead with this project." (letter
8/3/89)
October 25, 1989. Outside In still did not have a contract with
Multnomah County. I called Howard Klink, the county's Public
Relations Director, and said I'd received numerous calls from the
press regarding why we hadn't started the program. He said he'd
find out what the holdup was and advise the county they had a
potential media problem.
161
October 31, 1989. Outside In received a signed contract frqm
Multnomah County ..
November 1, 1989. Outside In opened the Needle Exchang(/,
Program. The media were not informed, as we feared no clients
would come if television crews with cameras were waiting to filn.1
them. On November 1, two drug injectors used the Exchange. Both
were youth (over age eighteen) from Outside In's Homeless Youtb
Program.
November 2, 1989. Day two. Three clients came, all from
Outside In's youth program. Staff turned away a seventeen year-old
female because she was too young to meet our legal requirements.
She cried and asked what she was supposed to do to protect herself.
November 1989. The state laboratory called. They refused to
process our hepatitis B tests without full names on each test. We
could not give them names, as we must protect the anonymity of ou;
clients. We needed the hepatitis tests done for the research
component. I called Robert O. McAllister, Ph.D. of the Oregon He'llth
Division's HIV Program. He and David Fleming, MD arranged for the
state lab to do core antibody tests without names, but not the surface
antigen test. The core antibody test would tell us if the person had
been exposed in the past two years. It wouldn't tell us if the person
was currently infected. If clients wanted that information, we would
refer them to a county clinic for an additional test.
November 3, 1989. Day three. An Outside In homeless yquth
client came to the Exchange. He said he was not a drug injector, but
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wanted to stClrt shooting speed to lose weight. He was turned away,
and an Outsipe In youth worker was asked to work with him.
November 6, 1989. Outside In called a press conference. A
young woman who was a client of the Exchange agreed to be filmed
with a false name land with her face blacked out.
The community I reaction was favorable with only two negative
phonr c::tlls. One was from an elderly woman who said she was
"upset we wquld let people like that in our organization." The second
was from a woman w,ho said she was concerned, and that giving out
syringes was "like providing rooms for rapists to rape in." We
received an a,dditional call from a woman who was a partner of a
drug injector. She had no opinion about the Exchange. She wanted
advice on how to handle the emotional stress of living with a drug
injector.
November 6, 1989. The First Unitarian Church, our neighbor
and landlord called. 'IThey provide a pre-school at the church. Their
courtyard is ;ldjacent Ito Outside In1s courtyard. The children playing
In their courtyard found two syringes. One child picked one up.
A Neec/le Exchange staff person and myself went to the church
and thoroughly searcqed the courtyard. We went through the
garbage, found the t\'% syringes and put them in a sharps container.
We made sure the child had not been stuck. I apologized and said I
would build fl barrier! tc the courtyard. It took a carpenter two days
to do so. Fqr those two days I personally went to the church each
morning and searched the courtyard for syringes.
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December 11, 1989. Thl,~ Oregonian printed a letter to the
editor by Mr. Bill Russell of the Union Gospel Mission. He said that
the Exchange is "aiding and abetting" drug injectors, and the
Exchange is operating illeg~lly Ibecause we give out cookers which are
classified as drug paraphernalia under the new paraphernalia law.
Ed Reeves, an attornH who had been advising us about the
Needle Exchange Program was Icontacted In order to classify as drug
paraphernalia, cookers mus~ be' "marketed for use or designed for
use ll for drug injectors.
Outside In gave out bottle caps (along with other items needed
for sterile injections), which aTl~ not marketed or designed for use by
drug injectors. However, they come with a cardboard liner which we
pop out. Our attrrney said stop giving them out, and we did. We
could give out spoons sinc~ wei wouldn't be altering them in any way,
but the cost was prohibitivt;. V1Ve decided not to give out cookers.
December 18, 1989. A l,nan named Mr. Arden called the clinic.
He said he was mugged in frO\lt of the Gentry Apartments (where he
lives) three or four days a~~o. :The Gentry Apartments are located a
block from Outside In and owned by Mr. DiLorenzo. He thought the
mugger injected him. He wanted to see a doctor at Outside In. The
Clinic Coordinator refused, and encouraged him to go to a hospital
emergency room.
December 27, 1989. The, Union Gospel Mission wrote to Gladys
McCoy, Chair of the Board of County Commissioners and asked her to
withdraw county support fpr the Needle Exchange Program.
164
January 21, 1990. Portland Medical Pharmacy called. The
pharmacist wanted to know if he could send drug injectors to the
Exchange. He's supportive of the program. He sells syringes in packs
of one hundred only, which some drug injectors can't afford. We told
him yes.
January 29, 1990. The Needle Exchange Program received
three positive HIV test results today. There have been a total of nine
positive results in the past three months. It is difficult on staff. I did
the first three-month follow-up interview today. I asked how the
client currently obtained his syringes. He said "here, at the Needle
Exchange." The struggles seemed worthwhile.
February 21, 1990. We decreased the amount of subject fees
from ten dollars to five dollars because the lobby had become a zoo.
Many people are more interested in earning the money than in using
the Exchange. Last night twenty-four people came in and we did
fifteen interviews. We had to set up an over-flow lobby in a back
room.
March 5, 1990. Outside In received five positive HIV test
results today. The cumulative total is now sixteen.
March 14, 1990. A drug injector came in who was very drunk
and high. He wanted to be interviewed and earn the five dollar fee.
The staff person told him he was too high, but he could come and be
interviewed tomorrow if he was sober. He grabbed the staff person
by the shirt, then left.
A buzzer was installed in the Exchange room that buzzed at the
reception desk. We added a note to the intake form stating "if you're
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under the influence, you may net be allowed to participate in the
study.1I I set up a training for staff on how to de-escalate violent
situations and how to handle angry clients.
March 27, 1990. There are now a total of twenty-one positive
HIV test results. Three were for people not participating in the
study. Two additional tests were equivocal.
March 27, 1990. Outside In started a support group for drug
injecting clients. The group was for drug injectors who are not ready
for treatment. The focus of the group was safer injection practices
rather than treatment.
The group never worked well. People were too dissimilar: the
non-street people didn't feel they had much in common with street
people. The long-time older heroin users didn't have much in
common with young cocaine users.
June ]991. Multnomah County again put fifty thousand dollars
In the upcoming 1991-1992 budget of the county health department
for the Needle Exchange Program.
August 1991. Multnomah County had an unexpected shortfall.
Two months into the fiscal year, the county health department
eliminated all funding for the Needle Exchange Program, effective
immediately.
Fall 1991. Outside In sent out a mailing to appeal to the
community for funding for the Exchange, and raised $5,000.
An emergency grant for $25,000 was requested from AmFAR.
While pending, I appealed directly to the Board of County
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Commissiqners I for $12,500 in emergency money. The commissioners
granted Outsid,e In the $12,500.
Janyary 1992. AmFAR granted Outside In the emergency
request of $25,000. On January16 I requested five minutes on the
agenda of a cCl>Unty commission meeting. I gave them back their
$12,500. They were very surprised -- it was the first time anyone
had ever ~iven money back to them.
Spri~g 1992. The Needle Exchange Program again had no
funding scmrcel for fiscal year 1992-1993. I talked with people at
the county, and called around the country. In the end,
Photographers land Friends United Against AIDS in New York granted
Outside In $2tJ,OOO, and Multnomah County granted the program
$5,000.
Spri~993. The Needle Exchange Program again had no
funding s()urcel for fiscal year 1993-1994. I wrote another grant
proposal to AmFAR. Despite high ratings from grant reviewers,
AmFAR declinled to continue funding for the Exchange. The position
of the BOf}rd of AmFAR was that as a foundation, their purpose was
to providet seed money to start needle exchange programs in
communities \vhich should then be picked up by local governments.
Outside Iri again appealed to the Multnomah County Board of
Commissioners.
Jun~ 29, 1993. The Board of County Commissioners set aside
$35,000 i~l cOl:ltingency funds for Outside In's Exchange, but did not
grant the funds outright to this agency. They asked me to request
funding £r'om the City of Portland based on a report from the city's
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Bureau of EnviJrOnmental Services which recommended support of
Outside In's; Exchange in order to reduce the number of discarded
syringes in stre~ts and rivers.
~1993. City Commissioner Mike Lindberg oversiiw the
Bureau of Bnvironmental Services. He said he would support
granting Ol\tside In $10,000 provided that it not be taken Ifrom his
Bureau of ~nvironmental Services budget, and cqntingent Ion the
county putHng U!p the other $25,000. CommissiQner Gretchen
Kafoury agreed to support his proposal. I needed one more vote,
preferably the mayor's.
I met with Mayor Vera Katz. She said she would support it,
and wOI.Jld take ,the money out of city contingency funds. II was to
consider th~se funds to be one-time-only funds.
Decer~ber 1993. The County Health Department agIieed to put
$40,000 in theirl base departmental budget for Outside In's Needle
Exchange Program for fiscal year 1994-1995. Fo,- the firstl time, I did
not hav~ to go ldirectly to the Board of County Commissioners and
request fur/dingi.
March 1994. Funding for the Needle Exch~nge Program is not
in the ~~ity'~; proposed 1994-1995 budget. A staff person from the
Confere~lce of Mayors called me. She said their llllnual meeting is to
be held in PortI.and in June 1994, and that fifteen mayors I would like
to visit the PorLland Exchange.
I call~d the mayor's office and told them. The $10,000 was put
back in the city I budget for the Exchange.
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March 1990. Outside In wanted to open a second Exchange site
In Old Town, the area of Portland which is a hang-out for many drug
injectors. Burnside Projects (now Transition Projects) was
ilpproacl.:ed, and negotiations begun for space in their shelter In Old
Town. The Executive Director, Jean DeMaster agreed to rent space to
Outside lin, but when she presented the proposal to her management
team, the alcohol/drug treatment people on her staff opposed it. In
the end tUley declined to rent to us, although they were apologetic as
they have experienced NIMBYism themselves.
Outside In approached Sisters of the Road Cafe in Old Town and
requested that we rent space and operate the Exchange during hours
the cafe was closed. Their Board of Directors said no. They had been
experIenCIng serious problems with their neighbors relating to drug
injecting dients, and had just resolved them. They were very
~upportive: and regretful, and asked if there was any other way they
could help Outside In.
We approached realtors to lease a space. None were interested
.lll our business. We drove around Old Town, copied down phone
numbers of places to rent and made phone calls. We found no one
who was willing to lease to us.
Ben and Tres, the managers of the X-Ray Cafe on Second and
Burnside ,contacted us. They had heard we were looking for space
,and offen:d their cafe. They talked with the owner of their building
,and obtained his approval. The cafe had a hall and room with a
~eparate entrance adjacent to the cafe that they offered to Outside In
for $40 per month.
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The second site at the X-Ray Cafe opened February 18, 1992.
It closed August 31, 1992 because Ben and Tres wanted to use the
space for something else. They contacied us several months later,
and re-offered the space to Outside In. We re-opened the second site
on December 4, 1992. The X-Ray Cafe (and the second site of the
Exchange) went out of business in August 1994.
Outside In opened a third site in December 1992 in North
Portland. A county HIV outreach worker offered joint use of his van
for outreach and needle exchange. It was parked at a fixed site in
the African-American community two days per week.
In the spring of 1994, Outside In sent a proposal to the Black
United Fund requesting $5,000 to open a fixed indoor site in
northeast Portland. They granted Outside In $3,000 for this purpose.
Outside In found a space in a building on Killingsworth near Martin
Luther King Boulevard. The man leasing us the space also obtained
the consent of the other tenants in the building for the Exchange.
The rent was a little more than our budget allowed. We contacted
Multnomah County, and the county agreed to pay Outside In $1,500
per year so that their HIV outreach workers could also use the site.
The site was scheduled to open mid-July.
However, some of the neighbors organized to keep the
Exchange from opening. They contacted the building owner and
were successful in getting her to deny us space in the building. The
man who leased us the space was not the building's owner (as we
thought) but was sub-leasing space to us. The neighbors also
contacted the county commissioners. The commissioners were
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supportive of Outside In, and Commissioner Hansen in fact contacted
the Health Department to arrange space for the Exchange in a county
clinic building on Martin Luther King Boulevard. This Northeast
Needle Exchange site opened November 1994.
APPENDIXC
UPDATED RESEARCH ON INTERNATIONAL NEEDLE EXCHANGE
PROGRAMS
Needle exchange programs first began in the Netherlands in
1984. Progrtams have now been established in nearly every country
in Europe, Canada, Australia, New Zealand and South America.
Presented here are data from the Netherlands, Australia and Canada.
The Netherlands
The N(~therlands originated the "harm reduction" approach to
dru~ injection. That is implementation of policies and programs that
are beneficial to both drug injectors and to communities, rather than
an insistence on abstinence and the "war on drugs" that is the
approach of policy-makers in the United States.
The Amsterdam Needle Exchange Program began in 1984 in
response to an outbreak of hepatitis B. It was started at the
insi~tence of! Amsterdam's "Junkiebond," a union of drug injectors.
There are currently fourteen exchange sites in Amsterdam, which
exc'lange approximately one million syringes annually.
The Amsterdam studies are interesting in that while first
repqrts indic~ted that drug injectors using needle exchange programs
significantly Ireduced risky needle use behaviors (Buning 1988),
repqrts soon Iafter were cautionary about attributing change in risky
beh<.lviors solely to needle exchange programs (van den Hoek 1989).
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A recent report by van den Hoek and Coutinho (1994) cpncluded that
although drug injectors in Amsterdam Qave Ichanged thejr behaviors,
this change cannot be attributed to anyone. program or intervenHon.
van den Hoek and Coutinho's study covered the period from
1986 to 1992, and showed that drug injectors using neec/le exchange
programs did reduce borrowing syringes (from 51 % to 20%), lending
syringes (from 46% to 10%), and re-usin~ syringes (from 63% to
39%). However, drug injectors not usin~ nel~dle exchange programs
made reductions in their needle-use beh~viors at the SaT\le rates. I
The authors concluded that Amsterdam'S! prevention programs as Ia
whole were responsible for change in b{i,havior. These programs
included not only needle exchange programs, but media campaigns,
legal sale of syringes, outreach and cou~lseliJllg, and metQadone
programs. That these programs are eff~ctive may be d~monstratled
by the fact that the HIV seroprevelence ratel has remain~d constaint
for seven years (since 1986) at about 30%. :As demonstn.lted by New
York, Edinburgh, Scotland and Bangkok, Thailand, once the infection
is established in a population, it can quickly nise to 40-50% (Des i
Jarlais 1987, Des Jarlais 1992b).
Australia
The Australian experience IS of interest because of the
unusually low HIV infection rate among drugl injectors. Wodak
(1994) reports that seroprevelence studies conducted between 1985
and 1991 reported rates at 5% or lower. This is unusual because lIlY
entered the drug injecting population in the early 1980's, the
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infection rate is high among the gay population, and there are close
links between the gay community and the drug injecting community.
Nevertheless, HIV infection rates among drug injectors remain at 5%
or less.
In 1985, politicians declared a public policy of harm reduction.
Needle exchange programs were begun in 1986, and had expanded to
all major cities by 1988. Exchanges in Australia are funded and
supported by the government. Syringes are legally available in
pharmacies. Education campaigns began in 1987. Capacity in
Methadone treatment programs was expanded by more than six
times from 1985 to 1993, and capacity is currently 13,000.
Three to four million syringes are exchanged annually in
Australia. The only negative effect of Exchanges reported by Wodak
(1994) was that for a brief time a high number of syringes were
discarded on the streets surrounding an exchange site. This was
dealt with by setting up special disposal boxes in public places, and
by giving special individual disposal containers to drug injectors.
Although clients of needle exchange programs reduced risky
needle use behavior over time, again this cannot be attributed solely
to the exchange programs. Multiple HIV prevention programs were
implemented at about the same time. The perception is that together
they account for the continued 5% or less infection rate among drug
injectors.
The perspective of Australia politicians is that there will likely
never be "proof" that programs such as needle exchanges work, and
such proof is not regarded as necessary before implementing HIV
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prevention programs, given the consequences of I an epidemic. The
debate in Australia is not whether syriinges ought to be legal, but
I
whether drugs ought to be. Prohibition is increasingly seen as
I
"expensive, ineffective, counter-productive and limpairs the
effectiveness of efforts to control the spread of HIV." (Wodak. 1994).
Their goal, unlike that of the United States, is t6 reduce the harmful
I
effects of drugs, not to simply reduce drug use.
Canada
Needle exchange programs started in Canada in Vancouver,
I
British Columbia in January 1989. By 1991, there were eight such
programs across Canada. These programs (except for Vancouver) are
I
supported and funded by the federal government.
The Canadian experience was similar to that i of the Netherlands
and Australia in that although evaluation of programs by Millson
I(1994) showed that clients of exchang1es reduced' risky needle use
I
behaviors, change could not be attributed solely Ito exchanges but
I
rather to comprehensive HIV prevention programs, including needle
I
exchange programs.
Toronto's Exchange, called "The 'Works," wi~s evaluated from
I
1989 to 1992. Millson reports that there were significant reductions
over time in sharing syringes, both giving them away after use, and
borrowing them. By 1992, 65% of drug injectors. did not share
syringes, compared with 55% in 1989. IUse of bleach to clean
syringes also increased significantly, from 51% in 1989 to 74% by
I
1991. Over a three-year period starting in 1989,1 there was no
i
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statistically sig\lificant change in the HIV infection rates among drug
injectors.
Needle Exchange CACTUS-Montreal opened in Montreal in 1989
(there are now eight exchange sites in Quebec). The evaluation of the
CACTUS-Montreal Exchange by Hankins (1994) showed that the
program attractli a particularly high risk male population. Attenders
of the Exchange were compared to a group of non-attenders. The
HIV infection rate among attenders was 20.5%, as compared to 4.8%
among non-attenders!. The evaluation also showed a decline in
loaning syringe~; from 31% to 20%, and an increase in bleaching
borrowed synn~es from 20% to 31%.
As III other countries outside the United States, needle
exchange is sef:,n as simply one component of a comprehensive HIV
prevention strategy. I The view is that all these programs together
influence behaviors of drug injectors -- whether or not they are
clients of anyone Iparticular program.
APPENDIX 4
UPDATED RESl~ARCH ON lJNI1fED STATES NEEDLE EXCHANGE
PROGRAMS
Since the two-year evaluation of the Needle Exchange Program at
Outside In in 1991-1992, evaluatiions of such programs elsewhere in
the United States h~ve I been cpnducted. Many of their findings
substantiate findings ofl the Ot.ltsidle In study. There are currently 33
needle exchange prqgrams in the United States, but not all of them
have evaluation components. Presented here are data from four
cities with the most extensive or I unique studies.
New Haven
Kaplan (1994,1) evaluateq the New Haven Needle Exchange by
developing a unique;. syringe tracking and testing system. Each client
was assigned a cod~~ nUlmber, cIS was each syringe. Evaluators could
then track whether a r'eturned syringe was brought back by the
client to whom it was given.
Syringes were tested for presence of HIV. Syringes from the
Exchange were compared with sy~ringes collected from shooting
galleries and other "street" sources.. HIV was found in 50% of
Exchange syringes, i.n 68% of \'street" syringes, and in 92% of syringes
collected from shoating galleries. I
Kaplan formulated a cir~:ulation theory. The more frequently
drug injectors used the I Exchange, I the less syringes were 111
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circulation, and the less likely they were to be shared. Frequent
users of the Exchange therefore have a decreased probability of HIV
infection.
Syringes returned to the Exchange by the client it w&s given 'to
were compared with syringes returned by a client to whom it had I
not been given. The latter were assumed to be shared syringes. HIV
was found more often in shared syringes (53%) than in thqse not
shared (43%). The evaluator then compared decreases in lilV
prevalence in both groups of syringes over time. Using mathematical
modeling, Kaplan estimated that the number of new HIV infections'
among drug injectors using the Exchange to be reduced by 33%.
The importance of this study is that it does not rely on self- I
report data. It attempts to verify by empirical means a d~crease in
sharing of syringes among clients of a needle exchange program. The
use of mathematical modeling to estimate the reduction in new HIV
infections has been criticized because of possibly questionable
underlying assumptions such as a shift in client demograpbics or I
behavior. However, subsequent examination of this by K~plan
(1994b) supported the original findings that estimated requctions iin
HIV were a result of decreased circulation time of syringes.
Other studies of residual blood in syringes show that the
amount of blood and even the type of syringe affect the extent to
which they are contaminated with HIV. Chitwood (1990) studied
syringes in shooting galleries in Florida. Syringes with visible
amounts of blood were four to five times more likely to be
contaminated with HIV than syringes without visible bloo~.
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Gaughwin (1991) found that 2ml I syringes were seven to ten times
more likely to have HIV than 1m) syringes. This latter finding could
have implications for n~edle exchange programs. While most
exchanges in the UniteQ States giN'e out primarily Iml syringes, many
offer a variety of syring;e and neeidle sizes. It may be that restricting
syringes to 1ml only is good publiic health policy.
New York
The epidemic of HIV among drug injectors affected New York
more than any other city in the United States. As reported by Peone
(1994), it is estimated that half olf the estimated 200,000 drug
injectors in this city are HIV posiltive.
New York state is one of the states with prohibitions against
the sale, distribution anQ possessio:n of syringes. However, the law
does allow the State He,dth Commissioner to declare a state of
emergency and grant a waiver to t.he law. The Commissioner did
grant such a waiver to qperate a f>ilot program in 1989, and a larger
program starting in 1992.
The one-year pilot study and needle exchange program began
In November 1988 as a small-scalle evaluation project. The program
had many barriers that prevented most drug injectors from using it.
For example, clients had to be on iwaiting lists for drug treatment
programs, and the Exchqnge was located in a government building
next door to a police station.
The program met with strong opposition, both from politicians
and from a segment of the Africa.n-American community who
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characterized the program as promoting genocide in that community.
The program was shut down in February 1990 with the election of a
new mayor.
In response to closure of the program, several illegal needle
exchange programs were started in 1990 by ACT UP (AIDS Coalition
to Unleash Power). In 1992, the State Department of Health declared
that the HIV epidemic among drug injectors was creating a public
health emergency, and granted a waiver for syringe exchange
programs conditional on their participation in an evaluation. Five
exchanges were then funded by the American Foundation for AIDS
Research in 1992, along with an evaluation component.
The evaluation was the most extensive one done to date in the
United States, with over 2,500 drug injectors interviewed over the
two-year study period. This study by Peone (1994) showed that
needle exchange programs were able to attract large numbers of
drug injectors. Approximately 1,000 drug injectors had used the
illegal exchanges. After legalization in 1992, over 26,000 drug
injectors used the Exchanges between then and September 1994.
Data from interviews with drug injectors using the Exchanges
was compared to data collected between 1990-1993 from drug
injectors using the Beth Israel drug detoxification program and a
storefront used for street-based research. There were significant
reductions in risky needle use behaviors: renting or purchasing used
syringes declined by 75%, using used syringes declined by 62%,
giving or lending used syringes to others declined by 50%, and
cleaning with bleach increased by 21%.
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Saliva samples were collected with each interview, and tested for
HIV. These samples showed a new infection rate of 2% per year, in
contrast to other studies of HIV infections in drug injectors in New
York which showed new infection rates of 4% to 8% per year. These
results indicate that syringe exchange programs in New York reduced
the incidence of HIV among clients by at least 50%. (Des Jarlais
1994).
San Francisco
California is also one of the states which prohibits the sale,
distribution and possession of syringes. A group called Prevention
Point started an illegal needle exchange program in November 1988.
The program was (and is) a fairly large-scale operation. In 1989,
approximately 1,000 ~;yringes were exchanged weekly. A year later,
over 4,000 syringes were exchanged weekly (Guydish 1993). By
October 1992, 13,000 syringes were exchanged each week (Watters
1994).
Watters (1994) conducted a 5.5 year evaluation of the
Exchange, from December 1986 until June 1992. The study looked at
many of the same questions as did the Portland Exchange. It
evaluated whether drug injectors would use the Exchange, whether
use of the Exchange would reduce sharing of syringes, whether
frequent attenders would reduce risky behaviors more than
infrequent attenders, and assessed the value of removing possibly
contaminated syringes from the streets.
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Drug injectors did use the Exchange -- despite the fact that it
was i}legal. The number of drug injectors using the program
increased steadily over the 5.5 years to 16,000 during a six-month
period in 1992. During the study period, 11 semi-annual surveys
were administered to drug injectors either on the street or in
treatment programs. Between 1989 and 1992, reported use of the
Exchange increased from 50% to 61%.
The number of drug injectors who reported the Exchange as
their primary source of syringes also rose steadily. By 1990, the
Exchange was reported by study respondents to be the major source
of syringes (45%, compared to 32% who bought them on the streets,
and 23% who obtained them from other sources).
Over the study period, the average age of drug injecting clients
of the Exchange increased from 35.8 to 41.6. Sharing of syringes by
respondents decreased from 66% in 1987 to 35.5% in 1992. Using
the Exchange 25 times or more in a year was a predictor of
infrequent sharing: these regular users of the Exchange reported less
sharing of syringes in the past 30 days than did infrequent users.
(Other predictors of less frequent sharing of syringes were increased
age, using condoms all the time, being African-American and
receiving HIV testing and counseling.)
By 1992, San Francisco's Needle Exchange Program was
collecting and safely disposing of 13,000 syringes weekly. As
reported by Watters, Guydish conducted a study which tested
residue in syringes collected from the San Francisco Exchange for
HIV. HIV was found to be present in 7% of a random sample of 83
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syringes. This means that in 1992, approximately 3,600
contaminated syringes were removed from the streets weekly by the
Exchange.
Guydish (1993) evaluated the San Francisco Exchange to assess
possible negative effects, specifically, whether it resulted in
increased IV drug use, frequency of IV drug use, increased sharing
of syringes, and an increased number of new drug injectors. Data on
the number of admissions to drug treatment programs in 1987-88
was compared to admissions in 1989-90 (prior to and after the
exchange began).
The percent of admissions of drug injectors decreased from
70.1 % in 1987 to 66.7% in 1990. Frequency of injection did increase,
although this reflects a trend that began several years before the
exchange began. Sharing of syringes decreased from 36.5% in 1987
to 24.8% in 1990 (although this also could be attributed to a trend
that began before implementation of the exchange). There was no
significant change in the number of clients repeating treatment who
switched from non-IV drug use to IV drug use. Finally, the areas of
the city with the lowest increase in the number of admissions to
treatment programs and the lowest increase in frequency of injection
were those areas with needle exchange programs. The study
concluded that needle exchange programs operating in San Francisco
did not have negative effects.
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Tacoma
Tacoma's Needle Exchange Program started In August 1988,
and was the first exchange in the United States. It currently
operates at four sites: a pharmacy, a mobile van, and two fixed sites
on the street. Approximately 50,000 syringes are exchanged
monthly.
A study by Hagan (1994) conducted interviews with 426 drug
injectors using the Exchange and compared them with interviews of
159 drug injectors not using the Exchange. This study showed that
drug injectors significantly reduced risky needle use behaviors after
using the Exchange. Prior to the Exchange, 58% injected with used
syringes, compared with 33% continuing to inject with used syringes
after becoming clients of the Exchange. Prior to the Exchange, 72%
passed on used syringes, compared to 46% after the Exchange.
Tacoma is located in Pierce County, one of four counties in the
United States used for hepatitis surveillance by Centers for Disease
Control. An epidemic of hepatitis B began among drug injectors in
Pierce County in 1985. It continued until after the opening of the
Needle Exchange Program, at which time it declined significantly, and
rates have continued to be low.
From January 1991 to December 1992, drug injectors who were
reported to have HBV were asked whether they had been clients of
the Needle Exchange Program, and how long they had been injecting.
Drug injectors with HBV were compared to a control group of drug
injectors without HBV. Those with HBV were eight times more likely
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to have injected for less than five years, and five times less likely to
have used the Needle Exchange Program.
The reduction of risky needle use behaviors suppprts the I
findings of the Portland study. The hepatitis B study is of
significance in that it helps corroborate self-report data,
